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Abstract
Bone biomaterials prepared from a combination of biodegradable polymers and bioactive glasses
offer several advantages, including favorable cell interactions, selective gene expression, and
delivery of biomolecules. Furthermore, the interaction of the organic and inorganic phases at the
molecular level results in a single-phase hybrid material possessing synergistic properties.
This research aimed to design bone biomaterials from α-amino acid-based poly(ester amide) (PEA)
and tertiary bioactive glasses using a sol-gel process. Since incorporating calcium into the
bioactive glass network is challenging at sol-gel reaction temperatures, calcium ethoxide and
calcium chloride were studied as precursors, and the optimum reaction conditions were identified.
Mesoporous silica nanoparticles loaded with a model drug were incorporated into the hybrid
biomaterials during scaffold fabrication to provide drug delivery capability. In an alternative
strategy, a hydrophobic model drug was loaded to the PEA, while a hydrophilic model drug was
loaded to the bioactive glass during the hybrid sol-gel microparticle synthesis. Data presented in
this thesis demonstrated the feasibility of delivering multiple biomolecules from these hybrid
biomaterials. Owing to the presence of the amino acid L-phenylalanine, the hybrid microparticles
were fluorescent with tunable emission by changing the excitation wavelengths ranging from 300
to 565 nm for potential multiplex imaging.
The PEA-bioactive glass hybrids were cytocompatible and promoted hydroxyapatite formation
from simulated body fluid. Moreover, the hybrid microparticles induced osteogenic differentiation
of 10T1/2 cells as a stand-alone system without biochemical factor supplements. Taken together,
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the data presented in this thesis demonstrated the potential of hybrid biomaterials for bone tissue
engineering applications.

Keywords: Bone tissue engineering, sol-gel process, organic-inorganic hybrid microparticles,
intrinsic fluorescence, poly(ester amide), bioactive glass, dexamethasone, dual drug delivery,
osteogenic differentiation
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Summary for Lay Audience
The increase in the elderly segment of the population has made the need for bone substitutes a
demanding task. Apart from age-related diseases, there are other reasons which can cause
substantial bone loss, such as fractures, congenital diseases, and tumor resections. Bone has a high
regenerative capacity; however, depending on the size of the defect, its anatomical location, age
and health background of the patient, and the state of surrounding soft tissue, many defects do not
heal spontaneously. For these defects, the current clinical approach is the use of autografts or
allografts. Autografts are bone harvested from another site in the patient body to be transplanted
into the defect site, while allografts are harvested from another human body, mostly a cadaver.
There are certain limitations associated with these approaches, such as limited availability of
healthy bone and disease transmission risk. Therefore, developing alternative solutions is essential
to meet the ever-increasing demand. Bone tissue engineering attempts to provide bone substitutes
by the use of natural or synthetic materials in combination with other elements such as (stem) cells
and biomolecules.
In this research, hybrid biomaterials consisting of a biodegrad able polymer derived from natural
amino acids, namely poly(ester amide) and bioactive glass, were synthesized. Hybrid material
scaffolds having silica nanoparticles embedded in them as a biomolecule delivery system were
fabricated. To study the hybrid material for drug delivery capability, hybrid microparticles with a
new synthetic approach were prepared. The microparticles could be loaded with two compounds
and were bioactive.
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The potential of the hybrid microparticles to promote progenitor cells differentiation to osteoblasts
(bone cells) through the release of ions from their structure and/or the release of the loaded drug
was investigated. Dexamethasone was loaded in the microparticles as the drug of interest.
In conclusion, this work introduced and investigated the potential of a specific organic-inorganic
hybrid biomaterial in the form of scaffolds and microparticles for the application of bone tissue
engineering.
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Chapter 1
1. Introduction
1.1.

Overview

Despite the high regenerative capacity of bone, defects with substantial bone loss do not heal
spontaneously. Common causes of considerable bone loss are trauma, injury, tumor resection, and
congenital diseases. Approximately 1.6 million bone grafts are used annually in the U.S. alone to
address bone defects in different anatomical locations.1 In addition, the increase of the elderly
population, has increased the demand for both hard and soft tissue substitutes. Current solutions
for providing bone substitutes (i.e., autografts and allografts) are not viable options due to donor
site morbidity, limited availability, disease transmission, surgical complications, variable clinical
outcomes, prolonged treatment time and/or multiple surgeries requiring patient commitment.2 The
field of bone tissue engineering emerged to accelerate the translation of new technologies to meet
the ever-increasing demand. While our knowledge about stem cell biology continues to grow, new
biomaterials or combinations of materials are also being developed. Mesenchymal stem cells are
the most frequently studied stem cells in preclinical research and clinical studies for treating
skeletal diseases.3 In terms of biomaterial constructs to support cells, apart from the chemistry and
composition, the processing and scaffold fabrication techniques are expanding, especially by the
growth of additive manufacturing techniques.4
The list of desired properties for a biomaterial has multiplied over the years.5 Biocompatibility,
tailorable degradation, and sufficient mechanical properties were the main requirements for a
tissue engineering scaffold; however, biomaterials are also expected to provide several features in
1

a single structure, such as defined nano- and micro-topographies, osteoconductivity, sustained
release of biomolecules, conductivity, luminescence property for bioimaging purposes, etc. to
direct cell fate and to mimic the microenvironment of repairing tissue.6 Moreover, the possibility
of undesired inflammatory reactions and infections contributes to the failure of bone grafts and
necessitates the development of platforms that can incorporate solutions to these complications
alongside promoting bone regeneration.7
The overall objective of this work is to design and synthesize organic-inorganic hybrid
biomaterials for bone tissue engineering in an attempt to provide several of the above-mentioned
features in a single structure.

1.2.

Thesis outline

This thesis is divided into six chapters. A broad literature review covering the physiology of bone
tissue, the current clinical strategies for the repair of bone defects, the use of organic-inorganic
biomaterials for bone tissue engineering, and different aspects of sol-gel synthesis is presented in
Chapter 2.6 At the end of Chapter 2, the hypothesis and objectives of the work are provided. The
research findings of the listed objectives are presented in Chapters 3-5. Chapter 3 focuses on
synthesis, physicochemical and structural characterization of poly(ester amide)-bioactive glass
hybrid material and amine-functionalized mesoporous silica nanoparticles along with fabrication
of hybrid scaffolds and their biological evaluation. 8 Chapter 4 describes the synthesis and
characterization of fluorescent poly(ester amide)-silica and poly(ester amide)-bioactive glass
hybrid microparticles.9 In Chapter 5, osteogenic differentiation of Mouse embryo multipotent
mesenchymal progenitor cells (C3H/10T1/2 cells) in the presence of pristine and dexamethasoneloaded poly(ester amide)-bioactive glass hybrid microparticles, compared to standard osteogenic
2

media is evaluated. Finally, a summary of the work, the strengths, limitations, and future directions
are outlined in Chapter 6.

1.3.
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Chapter 2
2. Literature review*
Overview. This chapter provides background information on the physiology of bone tissue, the
current clinical strategies for the repair of bone defects, and the current status of bone tissue
engineering with emphasis on the use of sol-gel derived organic-inorganic hybrid biomaterials.
At the end of the chapter, an outline of the scope of this work and the objectives are provided.

2.1.

Bone structure and biology

2.1.1.

Bone composition

Bone is a composite material with an intricate hierarchical structure on different levels, which has
been studied extensively not only from biological perspective but also from a materials engineering
perspective. Its composite nature with a highly structural organization, an orchestrated and
regulated turnover by different cell types, dynamic mechanical properties, and the continuous
adaptability to external mechanical loads make bone an interesting tissue in the body from a
materials and biological perspective. Bone plays many roles in the body, providing structural
support, protection of internal organs, and mineral storage, among others.
With regard to microstructure, bone can be categorized into two types, namely, cortical and
cancellous bone. Cortical bone (also known as compact or dense bone) is found in the outer shell
of long bones and cancellous bone (trabecular or spongy bone) can be seen in the interior space at
the end of long bones. Cortical bone is mainly responsible for bone stiffness and strength, while
cancellous bone is responsible for energy absorption and load distribution. 1
*Part of this chapter has been published. Reprinted with permission from (Aslankoohi, N., Mondal, D.,
Rizkalla, A. S., Mequanint, K.; Bone Repair and Regenerative Biomaterials: Towards Recapitulating the
Microenvironment. Polymers 2019, 11, 1437).

On the nanoscale, bone is made of an organic component, 90% collagen type I (32-44% bone
volume), and an inorganic component, hydroxyapatite Ca10 (PO 4 )6 (OH)2 (33-43% bone volume),
and water (15-25% bone volume).1 Apart from collagen, the remaining 10% of the organic
component of bone consists of non-collagenous proteins, including proteoglycans, osteocalcin,
osteonectin, growth factors, and so forth. The hydroxyapatite can have different ion substitutions
as well, CO 3 2- ions instead of hydroxyl or phosphate ions, Cl1- and F1- ions replacing hydroxyl ions,
HPO 4 2- ions instead of the phosphate ions, and Na1+ and Mg2+ ions instead of Ca2+ ions.2 There is
an interfacial layer of water between collagen molecules and hydroxyapatite crystals. The water
molecules interact with collagen and hydroxyapatite and are considered bound water. This water
shell has a major effect on the mechanical properties of bone. Apart from this hydration layer,
water exists in lacunae, canaliculi, and vascular canals of cortical bone as well. 2 Collagen
molecules have their known self-assembled fibrillar structure, and the hydroxyapatite crystals
interpenetrate within the collagen fibers. Studies have shown that bone specimens maintained their
integrity after demineralization or deproteinization, implying the interpenetrating network of both
organic and inorganic components in bone structure. On the sub-micron level, the mineralized
collagen fibrils self-assemble to sheet-like structures forming lamellae. Lacunae (place of
osteocytes) and canaliculi (connecting channels between lacunae) form in lamellae structure as
well. On the microscale, the assembled structures formed by lamellae distinguish bet ween the
cortical and cancellous bone. The arrangement of lamellae into concentric cylinders is seen in
cortical bone. The concentric cylinders are called osteons and are arranged around the Haversian
canal. A blood vessel is run through the Haversian canal, and the capillaries are distributed into
osteons. In cancellous bone, the lamellae arrangement is in the form of rods called trabeculae. On
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the macroscale, the dense structure of cortical bone and the porous structure of cancellous bone
can be seen.3
There are two main stages in bone formation (osteogenesis or ossification) referred to as primary
and secondary stages.3 In the primary osteogenesis, a woven bone microstructure is formed, which
is remodeled in the secondary stage. The collagen fibrils in the primary stage do not direct the
mineralization process considerably; therefore, the mineralization is unorganized, extrafibrillar,
and relatively fast. During remodeling, highly organized collagen fibers with interfibrillar
deposited minerals form which leads to concentric lamellae, formation of osteons, and the
Haversian canal system.4 The hierarchical structure of secondary bone is shown in Figure 2.1.

2.1.2.

Bone cells

Two types of stem cells reside in bone: hematopoietic stem cells (HSC) and mesenchymal stem
cells (MSC). HSCs differentiate into immune and blood cells and osteoclasts, while MSCs
differentiate into different lineages, including osteoblasts, and chondrocytes. Primary bone
resident cells are osteoblasts, osteocytes, and osteoclasts. Osteoblasts (from the differentiation of
MSCs) are mainly responsible for new bone matrix formation by secretion of collagen type I and
other ECM proteins. Two different types of osteoblasts, namely mesenchymal and surface
osteoblasts, are responsible for the primary and secondary stages of osteogenesis.
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Figure 2.1. Hierarchical structure of bone (A) Structure of cortical and cancellous bone (B)
arrangement of collagen and hydroxyapatite crystals on nanoscale.5

Mesenchymal osteoblasts form the primary woven structure, and surface osteoblasts create
lamellar structures in the secondary stage of osteogenesis. After this process, these osteoblasts
differentiate and mature to osteocytes residing in a collagen matrix. Osteocytes regulate bone
remodeling through interaction with osteoblasts and osteoclasts, secrete different proteins for
osteoblasts differentiation, regulation of mineral exchange, and so forth. Osteocytes play a role in
osteolysis as well, and are also responsible for the translation of mechanical cues to biological
signals. Osteoclasts are bone-resorbing cells in the bone remodeling process. Osteoclasts secrete
hydrogen ions for the dissolution of the mineral phase and cathepsin enzyme for digestion of
collagen type I and other insoluble parts of the matrix. The interaction of different types of cells
in the bone regulates and maintains bone resorption and formation balance. 5
7

2.1.3.

Cell sources for bone tissue engineering

Osteoblasts and their precursors are the primary cell sources for bone tissue engineering.6 Bone
marrow-derived stem cells (BMSC),7, 8 adipose-derived stem cells (ASCs),9,
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cortical bone

fragments mesenchymal stem cells (CBF-MSCs),11, 12 induced pluripotent stem cells (iPSCs),13, 14
and embryonic stem cells (ESCs)15 are potential stem cells to be utilized as osteoblast precursors.
BMSCs can be harvested from bone marrow aspirates and be expanded in culture. The harvesting
yield and the differentiation potency of BMSCs decline with the patient's age, which is one of the
main challenges for their use in the clinical application. ASCs are an easily accessible and abundant
source of precursor cells for bone tissue engineering. Liposuction is a convenient technique for
harvesting ASCs without affecting their functionality. The isolation of ASCs from the fat tissue
has a much higher yield compared to the isolation of BMSCs from bone marrow. 16 However, the
osteogenic differentiation capacity of ASCs is lower than BMSCs. 17, 18 ESCs are another cell
source for bone regeneration and their osteogenic differentiation process is well-explored.19 The
two main obstacles on the way of their utilization for bone tissue engineering are first, the ethical
issues associated with obtaining ESCs, and second the risk of tumor formation. 20 The iPSCs,
obtained through reprogramming of somatic cells, can address the ethical issues associated with
ESCs while maintaining the same pluripotency and lack of immunogenicity. However, the risk of
tumor formation still exists.21, 22
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2.2.

Critical size bone defects

2.2.1.

Definition

Bone is known for having a high regenerative capacity, enabling the repair of cracks and fractures
with or without surgical stabilizations (i.e., fracture fixation). Despite this intrinsic regenerative
capacity, many defects are considered critical size defects, i.e., they would not heal spontaneously
despite surgical stabilization and need further surgical intervention in the form of bone grafts.23
Management of critical size defects is a major clinical challenge. There is no universally accepted
defect size above which it is considered a critical size. Factors such as the anatomic location of the
defect, the state of soft tissue around the defect, presence of other underlying diseases, the quality
of bone, the age of the patient, and their lifestyle (alcohol consumption, smoking, diet) play a role
in the definition of the critical size defects. 24, 25 Making a distinction between non-union and
critical size defects may be noteworthy here. Non-unions can be classified as hypertrophic,
oligotrophic, and atrophic, with their main discerning factors as insufficient mechanical
stabilization, poor fracture apposition, and poor vascularity, respectively. The main reason for the
inadequacy of the natural restorative capacity of bone in healing the critical size defects is the
substantial bone loss and failure in bridging the physical gap, rather than an impaired and deficient
biological or osteogenic capability.26

2.2.2.

Current strategies for repairing critical size defects

Autograft bone, i.e., bone harvested from another anatomic position of the patient’s body, is the
current clinical gold standard for critical-size defects. Autografts provide the essential elements
for bone regeneration, namely osteoconductive matrix, osteoinductive signals, osteogenic cells,
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and sufficient blood supply.26 They also eliminate the risk of immunogenicity associated with other
donors. The iliac crest is a common donor site for harvesting the bone mainly because of the
potential to harvest a larger volume of bone. Other possible donor sites are the distal femur,
proximal tibia, and distal tibia.23 Despite the clinical success of autografts, they have several
disadvantages, including postoperative pain with potential reduced functionality or morbidity in
the donor site, limited availability and quantity of healthy bone to be harvested, and the need for
additional surgery for harvesting the bone, which can arise other complications such as infection.
Allograft bone harvested from donors, mostly cadavers is an alternative solution; however, the
limited availability of healthy bone and the risk of rejection and disease transmission are common
drawbacks. Xenografts (bone harvested from other species) are not considered as a viable approach
anymore due to the high risk of disease transmission and immunogenicity associated with them.

2.3.

Biomaterials for bone repair

Synthetic bone grafts emerged as alternatives to repair bone defects. Over the years, synthetic bone
grafts have evolved and covered a wide range of materials. Starting with inert materials as the first
generation, moving to bioactive and resorbable materials as the second generation, and cell- and
gene-activating materials as the third generation. 27 Third-generation biomaterials are attractive to
modulate the tissue microenvironment and stimulate cellular responses through the use of
bioactive materials dissolution products, immobilizing biomolecules onto the material, and many
other possible modifications.
The formation of fibrous tissue at the interface of material and native tissue was the common
drawback of inert materials, including metals and polymers. Bioactive glasses (BG), initially
developed by Hench, introduced the potential of favorable interfacial interaction. Dissolution of
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ionic species from the BG, provision of nucleation site, and subsequent deposition of a
hydroxyapatite layer lead to binding of the material to the native tissue. 28 As a result, the ability of
a material to deposit hydroxyapatite on its surface through incubation in simulated body fluid,
which has a similar ionic composition to human plasma, has been introduced as a standard test for
the evaluation of the ability of the material to bond to bone tissue in vivo, i.e. bioactivity of the
material.29 The Hench 45S5 BG, has a composition of 45 wt.% SiO 2 , 24.5 wt.% CaO, 24.5 wt.%
Na2 O and 6 wt.% P2 O5 .30 The introduction of bioactive materials was a significant step in
developing biomaterials for bone replacement. However, 45S5 BG is the brittle and the difficult
to process. Biomaterial scientists knew for a long time that fulfillment of various required
properties using a single material is impractical. Therefore, a combination of inorganic and organic
composite and hybrid materials were introduced as a viable option. This combination addresses
the shortcomings of organic materials in terms of cell-material interaction, inability to integrate
with native tissue, and inadequate mechanical strength.

2.3.1.

Organic-inorganic composites/nanocomposites

Using polymers as a matrix and inorganic materials such as bioactive glasses or hydroxyapatite as
a filler is a common approach in the preparation of composites.31, 32 Composites of biodegradable
polymers and BGs have shown improved mechanical properties in comparison to each component
alone.33,

34

However, the bioactivity of the inorganic phase and the favorable cell-material

interaction is diminished, as polymers coat the BG powder and cells initially come into contact
with the polymer. As a result, introducing the inorganic phase as a coating has been investigated
extensively, not only for polymeric materials but also for inert metal implants. However, the
provision of sufficient interfacial interaction is a challenging task. Surface modification by plasma
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treatment, heparin or polydopamine deposition, and many other methods have been reported to
enhance the attachment of the deposited layer.35-38
Another property that can be directly modulated through composite preparation is the degradation
rate of the material. The hydrophilicity of BG not only can increase the degradation rate of
composites but also can increase the pH of the environment containing acidic degradation byproducts of the polymers through the release of ions.39, 40 However, another challenge is to attain
a uniform degradation between the two phases to provide mechanical integrity for longer times. In
addition, the homogenous distribution of the inorganic phase in a nanocomposite is more
challenging due to the agglomeration of nanoparticles or nanofibers. To have consistent properties,
organic-inorganic hybrid materials with molecular-level mixing of the phases have been
investigated (see section 2.6 of this chapter).
Apart from choosing the right biomaterial, to engineer a functional tissue, having a sustainable cell
source is also essential, whether to be used for material screening and cell-material interaction
studies or to culture on the scaffold for implantation of a cellular scaffold into a defect site. The
use of stem cells from different sources for tissue regeneration is a growing field of research. Due
to issues associated with accessibility and proliferation, and differentiation ability of humanderived cells, the initial steps of material screening and cell-material interaction studies are
normally conducted using animal-derived cell sources. Murine mesenchymal stem cells with
osteoblast differentiation ability are frequently used cell lines for the initial stages of cell st udies.

2.4.

Sol-gel process for bioactive glass preparation

Silicate glasses are inorganic networks, initially prepared by quenching SiO 2 and P2 O5 melts as
network formers and CaO and Na2 O as network modifiers. When the sol-gel process was
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introduced for the synthesis of silicate glasses, the possible compositional variety of the glass
expanded, and the process was conducted at low temperatures. 41 The sol-gel process is a wet
chemistry process for the synthesis of silicate and bioactive glasses and is based on two
consecutive reactions of hydrolysis and condensation. The precursors are silicon alkoxides with a
general formula of Si-(OR)4 , in which R represents an alkyl group, for instance, tetraethyl
orthosilicate Si-(OC2 H5 )4 (TEOS) and tetramethyl orthosilicate Si-(OCH 3 )4 (TMOS). During
hydrolysis, the alkoxy groups are substituted with hydroxyl groups. In the subsequent
condensation reaction, the hydroxyl groups condense to form siloxane bonds (Si-O-Si) which
results in the formation of a network and ultimately the transformation of sol to gel. There are
different parameters in the sol-gel process that affect the reaction rate, the microstructure, and the
final morphology of the silicate network, including temperature, pH, and water/alkoxide ratio,
among others.

2.4.1.

Hydrolysis and condensation in sol-gel reactions

In hydrolysis reaction, an alkoxy group is substituted with a hydroxyl group through a bimolecular
nucleophilic reaction (SN2) between the oxygen of water and silicon atom with pentacoordinate
intermediates. In the case of acid-catalyzed hydrolysis, the protonation of the alkoxide group
makes the silicon more electrophilic and subsequently more susceptible to the attack of oxygen,
which reduces the positive charge of the alkoxide group and results in the displacement of alcohol
(Scheme 2.1). Under basic conditions, water may dissociate first and the nucleophilic hydroxyl
anions attack the silicon atom (Scheme 2.2).
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Scheme 2.1. Acid-catalyzed hydrolysis reaction.42

Scheme 2.2. Base-catalyzed hydrolysis reaction.42

Depending on the catalyst used and the progression of hydrolysis before the onset of condensation,
different structures can form as a result of condensation through a bimolecular nucleophilic
reaction (SN2). Under acidic conditions, silicon atom becomes more electrophilic due to the
protonation of silanol groups hence, more susceptible to the nucleophilic attack of a neutral silanol
group (Scheme 2.3). Condensation occurs preferentially between monomeric silicate species and
terminal silanols resulting in chain-like structures, network formation, and eventually gelation.
Under basic conditions, the attack of a nucleophilic deprotonated silanol on a neutral silicate
species results in siloxane bonds (Si-O-Si) (Scheme 2.4). Substitution of -OSi instead of -OH or OR groups reduces the electron density of Si atom and subsequently increases the acidity of the
remaining silanols; therefore, more condensed species (which have silanols with a higher acidity)
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react favorably with less condensed species. As a consequence, highly branched species form
which lead to colloidal particles.

Scheme 2.3. Acid-catalyzed condensation reaction.42

Scheme 2.4. Base-catalyzed condensation reaction.42

As can be seen in reactions presented in Scheme 2.3 and Scheme 2.4, water is generated as a result
of condensation reaction; therefore, a H2 O/TEOS molar ratio of 2 is sufficient for hydrolysis and
condensation with a general reaction shown below.
n Si(OR)4 + 2n H2 O → n SiO 2 + 4n ROH
However, it should be noted that even in the presence of excess water, the reactions do not proceed
to completion and different intermediate species are present in a mixture. A direct effect of
increasing the H 2 O/TEOS ratio is the acceleration of hydrolysis reaction, while simultaneously, a
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high amount of water results in dilution of the mixture and subsequently increases the gelation
time. Moreover, it can promote the reverse reactions of Scheme 2.3 and Scheme 2.4.

2.4.2.

The effect of pH in sol-gel reactions

Acids and bases are more than mere catalysts in the sol-gel process. They can affect the
morphology of silicate glasses. The pH spectrum can be divided into three distinct regions for the
sol-gel synthesis of silicates with respect to the isoelectric point of silica (at pH ~ 2), pH < 2, pH
> 7, and pH between 2 and 7. For pH below 2, the rate of hydrolysis is higher compared to the rate
of condensation. The solubility of silicate species formed by hydrolysis and condensation is low
(hydrolysis of siloxane bond is low); therefore, it is not expected that Ostwald ripening of the sol
particles to occur (no dissolution and restructuring). On the other hand, due to the low ionization
of the particles, there are no repulsive forces between them. Therefore, after initial particle
formation with the sizes exceeding 2 nm, aggregation and subsequently gelation due to the
formation of an interconnected network of the chains occurs. In the pH range of > 7, the solubility
of silicate species increases and provides a source of monomers for restructuring; therefore, the
occurrence of Ostwald ripening is probable and leads to an increase in the size of initially formed
particles in the sol. On the other hand, due to ionization of these particles and subsequent repulsion
between them, a suspension of particles forms, which unlike the case of pH < 2, does not lead to
aggregation and gelation (however, in pH above 12, gelation may occur). In the pH ranges between
these two extremes, both scenarios of aggregation and ripening are possible and the gel time
increases with the decrease of the pH in this range. 43 In other words, in the intermediate pH range,
the dissolution and condensation rates increase with pH while the hydrolysis rate decrease. On the
other hand, increasing the H 2 O/TEOS ratio increases the hydrolysis and dissolution rates at a given
pH. Figure 2.2 shows the effect of pH on the final structure of silicates.
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Figure 2.2. Effect of pH on the final structure of silicate gels.44

2.5.

Silica / Bioactive glass nano- and micro-particles

Silica and bioactive glass particles have been widely investigated for bone tissue engineering. In
this section, an overview of different approaches used for the synthesis of silica and BG particles
using the sol-gel process is presented.

2.5.1.

Base-catalyzed sol-gel process

From the synthetic perspective, the vast majority of silica-based particles are taking advantage of
the known Stöber process,45 in which the sol-gel process under highly basic conditions results in
17

monodisperse particles in the size range of 0.05-2 μm. Over the years, the Stöber process has been
modified to incorporate other elements such as calcium,46 copper,47 etc. in the process or organic
species as an aid to better control the morphology and dispersibility of particles.48 Mesoporous
silica/BG particles have been also prepared by the Stöber process under the presence of a structuredirecting agent.49, 50 Although the Stöber process is a well-established synthetic approach for the
preparation of BG particles, subtle changes in the process can have a considerable effect on the
structure of particles. For instance, it has been reported that changing the timing of the addition of
calcium nitrate (as a calcium source) to the sol affects the morphology of the particles, with larger
and more homogeneous particles obtained by delayed addition of calcium nitrate. 51

2.5.2.

Acid / base (two-step) catalyzed sol-gel process

Given that the sol-gel process under basic conditions can result in particulate morphology, an
initial acid-catalyzed system can result in particulate morphology by shifting the pH to the basic
region.52 One of the reasons for utilizing such a system instead of simply a base-catalyzed sol-gel
process is accelerating the hydrolysis reaction. Hydrolysis is faster under acidic conditions, while
condensation is faster under basic conditions. Therefore, by using a two-step process, the overall
reaction rate can be increased. To have a better control over the final morphology and prevent the
formation of a gel network, weak organic acids can be used as a catalyst for the first step.53 Particles
produced by this method normally have a rough surface topography. 54 Apart from spherical
particles, hollow particles55 , and other particulate morphologies56 have also been synthesized by
this approach.
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2.5.3.

Acid-catalyzed sol-gel process

There are few studies in which an acid-catalyzed sol-gel process without increasing the pH to basic
conditions has been used to prepare silica/BG particles. Unlike the Stöber process, the mechanism
of particle formation under acidic conditions is not well-understood. Emulsion,57 nucleationaggregation-growth,58 and phase separation-aggregation59 are different mechanisms suggested to
explain the formation of particles. In several studies, a water-soluble polymer such as poly(sodium
styrenesulfonate),60 poly(acrylic acid),61 PEG,62, 63 and chitosan64 has also been added to the acidic
sol-gel process, which mostly acted as a phase-separation agent and has been removed by
dissolution or calcination after the synthesis. Amphiphilic block copolymers such as Pluronic
F12765 and P12366 are also among polymers introduced into the acidic sol-gel process and resulted
in the formation of mesoporous silica particles after their removal. In the case of poly(sodium
styrenesulfonate)-silica and poly(acrylic acid)-silica systems, the obtained particulate morphology
has been explained by a combination of spinodal phase separation and gelation. The driving force
of phase separation is the polymerization of silica. The addition of polymer leads to an increase of
equivalent temperature of binodal phase separation (Teq,b ) to the point that it becomes equal or
larger than the equivalent temperature of gelation (Teq,g); therefore, phase separation occurs. The
difference between Teq,b and Teq,g defines the final morphology, which in turn is dependent on
several factors such as solvent, temperature and molecular weight of polymer.67

2.5.4.

Combination of the sol-gel method with other processes

One of the frequently used methods for the preparation of polymeric particles is the emulsion
technique. A combination of microemulsion and the sol-gel process has been used to produce silica
and BG particles.68 Basically, the droplets in an emulsion act as a reactor for the sol-gel process
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and the reaction proceed in a confined space which directs the obtained morphology. Water-in-oil
(W/O) microemulsions have been mainly used to prepare BG particles with the aqueous phase
containing the glass precursors and a catalyst. After the preparation of the particles, extensive
washing steps are required to remove the residual organic species of the oil phase and emulsionstabilizing surfactant from the surface of particles. Mesoporous bioactive glass particles have also
been prepared by using microemulsion-assisted sol-gel reaction.69, 70
Another technique for the preparation of BG particles is the combination of the sol-gel process
with aerosol technology. The basic principle is similar to the emulsion technique; here the aerosol
droplets act as a reactor, and the sol-gel process in a confined droplet space results in particulate
morphology.71 In addition, the combination of acid-catalyzed sol-gel process and aerosol
technology can also be used to prepare particulate morphology.72 Aerosol technology provides the
possibility of large-scale particle production; however, the obtained particles usually have a
polydisperse size distribution. Moreover, as the use of high temperatures is inherent to the aerosol
technique, direct incorporation of the organic moiety in the sol is not feasible. A UV-aerosol
technique based on photopolymerization has been developed to produce silica and organosilica
particles.73 Spray drying, in which sprayed particles are deposited in a pre-heated surface, has also
been combined with the sol-gel process.74 Combination of the sol-gel process with electrospraying
has also been used for the production of silica and BG particles.75

2.5.5.

Mesoporous silica nanoparticles

Mesoporous silica nanoparticles (MSNs) have been under scrutiny for biomedical applications.
There are innumerous studies on the use of MSNs as a carrier for delivery systems.76 Many
elaborate and complex designs have been utilized to control the release profile of the compound
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loaded in MSNs, from the use of gate-pore structures to stimuli-responsive macromolecules.77, 78
Different anticancer drugs, contrast agents and dyes, growth factors, enzymes, and many other
molecules have been loaded inside MSNs. Among various applications proposed for MSNs such
as imaging aid and cancer therapy, the use of MSNs for hard tissue regenerat ion is the most
prevalent one.79 Apart from the high surface area of MSNs due to their mesoporosity (pore size in
the range of 2-50 nm), which makes them popular as a delivery vector, the release of Si ions upon
their gradual dissolution is particularly interesting for hard tissue regeneration application. The
synthesis of MSNs through the sol-gel process in the presence of a surfactant as a structuredirecting agent or a template is well-established.80 Cationic surfactants such as CTAB
(cetyltrimethyl ammonium bromide) and Pluronic copolymers of ethylene and propylene oxides
such as P123 (EO20-PO70-EO20) and F127 (EO106-PO70-EO106) are among common
surfactants used as a template. After the synthesis, removal of the template by calcination or
extraction results in the appearance of mesopores. Mesoporous nanoparticles with different
morphologies (sphere, rod, etc), different particle sizes, and different pore sizes have been
synthesized. Different functional groups have also been introduced on the walls of mesopores for
cargo conjugation or on the surface of nanoparticles to conjugate targeting moieties. To
functionalize MSNs, two different approaches are commonly employed, namely post-synthesis
grafting and co-condensation.81 As the name implies, in post-synthesis grafting, the MSNs are
synthesized in the initial step, and then they are functionalized in the second step. The silanol
groups (Si-OH) are used as an anchoring point to link the functional groups of interest (Scheme
2.5). Since functionalization is conducted after the synthesis of MSNs, post-synthesis grafting does
not change the mesopores’ size and order. However, it usually results in non-uniform distribution
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of functional groups, with a great portion of them present on the outer surfaces of the particles or
near the opening of the pores.

Scheme 2.5. Functionalization of MSNs through post-synthesis grafting (e.g. silylation).81
In the co-condensation method, the organoalkoxysilane bearing the functional group of interest is
introduced into the sol-gel process, and subsequently, by hydrolysis and condensation of both tetraalkoxysilane and organoalkoxysilane, functionalized MSNs are obtained (Scheme 2.6). Although
the synthesis protocol may need some adjustment for control of mesopores’ size and order due to
the introduction of the organoalkoxysilane, the co-condensation method results normally in
uniform distribution of functional groups in the pore walls and better control on the amount of
incorporated functional groups.
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Scheme 2.6. Functionalization of MSNs through co-condensation method.81

2.6.

Organic-inorganic hybrid bone biomaterials

The interaction between organic and inorganic phases on the molecular level results in a
homogenous distribution of the two phases and subsequently uniform and consistent properties.
The distinguishing feature of organic-inorganic (O/I) hybrids compared to the composites is the
fact that in hybrids, the phases are indistinctive on the nanoscale, and the two phases form an
interpenetrating network. Therefore, it is expected that the hybrid acts as a single-phase material,
having not only intrinsic physicochemical properties of its components but also new synergistic
properties.
The presence of organic components necessitates the use of a low-temperature synthetic approach.
Therefore, the melt-quenching method in which constituents’ oxides are melted together at high
temperatures (>1300°C) and then quenched and was conventionally used for the synthesis of
inorganic glasses cannot be utilized here. The sol-gel process, as discussed in section 2.4, is a
versatile and viable approach for the synthesis of not only inorganic glasses but also O/I hybrids.
The organic and inorganic phases are intrinsically incompatible with each other, therefore,
successful hybridization and obtaining biomaterials with homogenous structure is a challenging
task and can be carried out through the provision of interactions between the two phases. Based
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on the nature of interactions, hybrid materials are categorized into class I hybrids in which the
organic and inorganic phases have molecular interactions of the nature of van der Waal’s,
hydrogen bonding, or electrostatic interactions and class II hybrids with chemical interactions such
as covalent bonding between the components (Figure 2.3).82

Figure 2.3. Schematic illustration of the distribution of phases in a composite versus class I or
class II hybrid.83

Due to the aqueous nature of the sol-gel process, initially, water-soluble polymers such as PVA,84
PEG,85 and gelatin86 have been introduced into the sol-gel process to synthesize O/I hybrid
materials. However, many degradable and biocompatible polymers are water-insoluble. Using
water-miscible organic solvents as co-solvents during the sol-gel synthesis to prevent the polymer
from being phase-separated or precipitated and employing non-aqueous sol-gel synthesis route87
are adopted approaches to introduce a greater variety of polymers into the hybrids. Methyl ethyl
ketone (MEK),88 hexafluoro-2-propanol (HFP),89,
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tetrahydrofuran (THF),91 and N,N-

dimethylformamide (DMF)92 are different water-miscible organic solvents that have been used to
incorporate polymers such as PCL, PHB, and PLLA into the glass network.

2.6.1.

Calcium incorporation in silicate glasses and organic-inorganic
hybrids

Different inorganic elements have been incorporated in the silicate glass networks to fulfill
different functional and biological roles.93 Phosphorous, calcium, boron,94-96 magnesium,97
manganese,98 zinc,99 copper100 , and strontium101-103 are among the different elements introduced
to the silica network. For the application of hard tissue regeneration, calcium is the most important
element to be included in the glass network. Hydroxyapatite, the inorganic component of the bone,
contains 99% of the calcium in the body.104 In vitro cell studies have clearly shown the
fundamental effects of the calcium ions on osteoblasts and osteoprogenitor cells in terms of their
adhesion, proliferation, differentiation, and signaling cascades in bone regeneration.105 The
calcium homeostasis in the bone is maintained through two main pathways. First, through bone
remodeling processes, by the action of osteoclast and osteoblasts, and second, through ion
transport across bone surfaces. Therefore, osteoblast progenitors are exposed to the calcium ions
as a degradation product of resorbed bone by osteoclasts in the tissue remodeling
microenvironment, which affects their differentiation. 106 While bone turnover maintains the longterm calcium level, the short-term calcium concentration is maintained by calcium ion transport
across quiescent bone surfaces.107 It was shown that calcium ions and BMP-2 cooperatively
enhanced the differentiation of osteoblastic progenitor cells. 108 Exposure of human bone marrowderived mesenchymal stromal cells to a high concentration of extracellular Ca2+ resulted in
increased proliferation, expression of osteocalcin, osteopontin, bone sialoprotein, and a 3-fold
increase in the expression of BMP-2.109, 110 Another study on the exposure of mouse bone marrow25

derived mesenchymal stem cells to elevated concentration of extracellular calcium ions has also
shown the promotion of cell proliferation, matrix mineralization, and MSCs migration through the
expression of osteopontin.111 The pivotal effect of calcium on osteoblasts and their progenitor cells
is not only limited to 2D culture and has also been shown in 3D scaffolds for bone tissue
engineering.112-114
Calcium ions are introduced to the silicate network as a network modifier, which means that they
are incorporated in the network through the ionic bonds with two non-bonding oxygens (NBO).
Consequently, their incorporation reduces the network connectivity of the silicate glass. The most
frequently used calcium precursor for the introduction of calcium to the sol-gel process is calcium
nitrate [Ca(NO 3 )2 ], although it may lead to an inhomogeneous distribution of calcium in the
structure.115 With a thermal treatment, calcium nitrate crystallites decompose, and calcium is
incorporated in the silica network. It is shown that the calcium ions from calcium nitrate would
only be incorporated in the silica network with heat treatment at temperatures of > 400°C. 116 In
the case of calcium nitrate, heat treatment is also important to remove toxic nitrate. Nitrate
completely decomposes at a temperature of ~500°C.117 It should be noted that the necessity of the
heat treatment for the calcium to be incorporated in the glass network makes the incorporation of
calcium in the glass network of an organic-inorganic hybrid, using calcium salts as a precursor
impractical. Such a high-temperature thermal treatment is not compatible with the organic
component of the hybrid and leads to its decomposition. An alternative approach to introduce
calcium in the glass network of an organic-inorganic hybrid at low temperatures is using calcium
alkoxides as a calcium precursor in the sol-gel process. Calcium alkoxides readily hydrolyze
alongside other alkoxide precursors such as silicon alkoxide and phosphorous alkoxide. However,
the high sensitivity of calcium alkoxides towards water leads to an uncontrollable reaction. Their
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fast hydrolysis results in an increase of pH, which subsequently accelerates the hydrolysis and
condensation of alkoxysilanes, and uncontrollable and fast gelation occurs.118 Therefore, the use
of calcium alkoxides in the synthesis of an O/I hybrid not only can result in inhomogeneity of the
phases119 but also would not spare enough time for processing of the hybrid or scaffold fabrication.
Due to the scarcity of an appropriate calcium precursor to conveniently incorporate calcium in the
inorganic network of the hybrids, many O/I hybrids lack calcium oxide as a component of the
inorganic phase and have an inorganic network solely based on silica and other elements than
calcium or have used calcium salts such as calcium chlorid e (not calcium nitrate due to the toxicity
of the nitrate ions if not removed by thermal treatment) to entrap calcium ions in the silica network.
However, it should be noted that calcium ions that are entrapped physically in the glass network
can diffuse out easily upon contact with water or biological fluids. This burst release of ions might
cause an abrupt pH change locally and also provoke cytotoxicity. 112, 120 In summary, calcium
alkoxides are potential candidate precursors for hybrid synthesis by the low-temperature sol-gel
process. Calcium ethoxide and calcium methoxyethoxide are the two most studied calcium
alkoxides.121-123 Recent studies have tried to control the sol-gel reaction rate in the presence of
calcium ethoxide to some extent by working in dilute conditions and providing a minimal amount
of water, to be able to provide time for processing of the hybrid prior to complete gelation.124, 125

2.6.2.

Organic-inorganic colloidal nanocomposite/hybrid particles

The organic-inorganic materials can be processed to fabricate scaffolds with different geometries
using different scaffold fabrication techniques such as 3D printing, electrospinning, phase
separation, and salt leaching. Among different possible morphologies of organic-inorganic
materials, spherical particles have an interesting morphology. Micro- and nanoparticles with an
increased surface area can be used as fillers in composites, incorporated into hydrogels to tailor
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their mechanical properties for hard tissue regeneration, used in injectable formulations, or as
biomolecule delivery carriers.
Polymer-silica nanocomposite and hybrid particles have been under scrutiny specifically from the
synthetic point of view. Many intricate synthesis approaches have been developed to produce
polymer-silica particles.126-131 It should be noted that the term polymer-silica colloidal
nanocomposites or hybrids, although sometimes used interchangeably, covers many different
particulate morphologies; however, a distinction between hybrid particles and colloidal
nanocomposites is needed. Hybrid particles have a homogenous inner structure, having an
interpenetrating network of the polymer and silica within the particles,132 while in colloidal
nanocomposites, one of the components has formed particulate morphology separately, and these
particles are detectable in the structure of the final colloidal nanocomposite using techniques such
as transmission electron microscopy. Based on this distinction, the synthesis approaches can be
categorized

into

two different groups:

Core-shell

polymer-silica

particles

(colloidal

nanocomposites) and polymer-silica hybrid particles.
In core-shell polymer-silica particles, preformed organic or inorganic particles act as a
core/substrate for the formation of the inorganic or organic shell, respectively.133 Combination of
Stöber process with seeded polymerization has resulted in various morphologies beyond normal
core-shell structure such as raspberry-like and currant bun,134 snowman,135 and guava-like127
particles, to name a few. Core-shell polymer-silica colloidal nanocomposites can be divided into
two groups: i) polymer core coated with a silica shell by sol-gel process, and ii) silica core with a
polymer shell by in situ heterophase polymerization and surface-initiated polymerization. Selfassembly is another technique that can be used for both types of cores.
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In the case of particles with polymeric core, in order to coat the polymeric core with a silica shell
through the sol-gel process, the incompatibility of polymer and silica should be circumvented.
Two approached are commonly used: (i) functionalization of the polymer itself, or (ii)
functionalization of preformed polymeric particles.
One of the initial studies suggesting approach (i), used emulsion polymerization to copolymerize
styrene and (3-mercaptopropyl)trimethoxysilane (MPS) and simultaneously prepared polymeric
particles. Then these particles were used as a core, and a silica layer as a shell was deposited on
them by the sol-gel reaction of TEOS and trimethoxysilyl groups of the copolymer under basic
conditions. The thickness of the silica shell could be controlled by the concentration of TEOS. The
size of final core-shell particles was changed in the range of 165-220 nm by changing the
concentration of TEOS. It was observed that when poly(styrene) particles were used instead of
poly(styrene-co-MPS), the silica layer was deposited as small silica beads instead of a smooth
silica layer and free silica particles were also formed.136
In approach (ii), the polymeric particles were first prepared and then modified before the
deposition of the silica layer. In a study by Graf et al., cationic or anionic poly(styrene) particles
were first prepared by surfactant-free emulsion polymerization. These particles were then coated
with poly(vinylpyrrolidone) (PVP) by adsorption, followed by the deposition of silica shell by the
sol-gel process under basic conditions. It was reported that the length of the PVP chains influenced
the stability of the colloids and the homogeneity and smoothness of the silica coating. 137
In the case of particles with silica core, silica particles act as a seed for in situ heterophase
polymerization, which results in a polymeric shell on the silica core particles. The silica core
should be functionalized to provide interaction with the polymeric shell, and this can be achieved
by either chemical or physical interaction or adsorption of one of the main ingredients of the
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polymerization such as monomer or initiator on the surface of silica particles. After this
modification, different types of polymerization can be utilized for deposition of the polymeric
shell, such as i) seeded emulsion polymerization,135 ii) seeded surfactant-free emulsion
polymerization,138 iii) mini-emulsion polymerization,139 iv) dispersion polymerization,140 and v)
surface-initiated polymerization.141-143
Self-assembly is another method for the preparation of core-shell colloidal nanocomposites and
relies on the spontaneous organization of organic and inorganic components by noncovalent
interactions such as electrostatic interaction and hydrogen bonding. Layer by layer self -assembly
(LbL) is one of the extensively studied approaches which employs the electrostatic interaction for
the arrangement of different layers. Silica particles or polymeric particles such as poly(styrene)
particles are the starting point of the synthesis, acting as a core on which different layers are
deposited. The core particles may be removed after the assembly to prepare hollow particles or
capsules to be used for drug loading and various other applications. However, in the classification
presented here, to be counted as colloidal nanocomposites, the final particles should have both
organic and inorganic components. The pioneering work on LbL self-assembly of nanocomposite
particles was conducted by Caruso, in which multilayers of 25 nm silica particles and
poly(diallyldimethylammonium chloride) (PDADMAC) were deposited on the poly(styrene)
particles144 using electrostatic interaction.
Silicate-based particles containing either an organic moiety or a polymer have been categorized as
hybrid particles. In both cases, most of the synthetic approaches have taken advantage of the
known Stöber process, sometimes with the aid of a surfactant. The organic moiety has been
introduced into the Stöber process through different approaches: i) by functionalization of an
organic molecule with alkoxysilane groups and subsequently the hydrolysis and condensation of
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these organoalkoxysilanes,145 ii) by co-condensation of organoalkoxysilanes (such as
aminopropyltriethoxysilane) alongside a silicon alkoxide, 146 and iii) by using bridged
polysilsesquioxanes [(R´O)3 -Si-R-Si-(OR´)3 ] as a precursor, in which the organic part (R) is
inserted in the middle of the chain between two alkoxysilane groups.147, 148 Functionalized
mesoporous silica

nanoparticles

through co-condensation of organoalkoxysilanes

and

alkoxysilanes have been considered as hybrid particles as well.149
In the case of polymer-silica hybrid particles, introducing the polymer into the sol during silica
particles formation has been extensively investigated for various polymers. For hydrophobic
polymers, this means essentially sol-gel process in an emulsion setting. Here, an oil-in-water
emulsion is prepared, in which TEOS as the silica precursor, the hydrophobic polymer with or
without an organic solvent, and a surfactant constitute the oil phase, while a basic ethanolic phase
constitutes the water phase. Silica-PDMS hybrid particles have been synthesized by the
combination of the Stöber sol-gel process and an emulsion.150 PDMS was first dissolved in TEOS
with the aid of THF for high molecular weight PDMS. The mixture was then emulsified in a
mixture of ethanol, ammonium hydroxide, and a surfactant. The type of the surfactant was
determined to be the most influential factor as anionic SDS, cationic CTAB, and nonionic Triton
X-100 surfactants all failed to form a stable emulsion. The employed surfactant, DOW-190, was
composed of an oligomeric PDMS chain linked to an oligomeric EO/PO copolymer. 150 Using the
similar procedure of combination of the Stöber process and emulsion, or in other words,
entrapment of an organic polymer in polycondensing silica within oil-in-water emulsion stabilized
by a selected surfactant, different hybrid particles have been synthesized such as polyethylenesilica particles,151, 152 poly(L-lactic acid)-silica particles,153 and poly(styrene)-silica particles.154
Combination of mesoporous silica particles synthesis and an emulsion has also resulted in hybrid
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mesoporous particles. Mesoporous polycarbonate-silica spheres have been synthesized by this
method and the P123 surfactant used for mesopores creation was removed by extraction instead of
calcination, so the polycarbonate remained in the silica network. 155
The sol-gel process can also be acid-catalyzed. To incorporate hydrophilic polymers such as PEG,
a combination of the water-in-oil emulsion and acidic sol-gel process has been used.156 However,
as discussed in section 2.5.3, there are few studies on the incorporation of a polymer in the sol-gel
process and the formation of particles under acidic conditions. In all of these studies, only watersoluble polymers,62, 64, 157 or amphiphilic block copolymers158 have been introduced into the solgel process, and the polymer has been removed by dissolution or calcination after the process.

2.6.3.

Type of organic component of hybrid bone biomaterials

Various polymers have been investigated as the organic component of the hybrids. For the
biomedical application, the first prerequisite is the biodegradability of the polymer so the hybrid
material can be gradually replaced with the newly formed tissue. Therefore, polymers such as
polydimethoxysilane
copolymers161,

162

(PDMS),159

polystyrene,160

poly(methyl

methacrylate),

and

its

and poly(2-hydroxyethylmethacrylate)163 that have been introduced as the

organic component of the hybrids, may not be viable options for bone tissue engineering
application. Among biodegradable polymers, known polyesters such as PCL, 164 PLLA, PLGA,
etc. have been studied extensively as an organic component for class I or class II hybrid materials.
Amino acid-based polymers are another category of synthetic polymers which can be considered
as protein analogs and hold great potential for tissue engineering and drug delivery applications.
They offer many advantages specifically for biomedical applications: (i) improved cell-material
interaction due to the presence of amino acids in their structure, (ii) versatile chemistry for
modification to introduce new functionalities and pendant groups for imaging, drug delivery, and
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molecular targeting purposes, and (iii) non-toxic and metabolizable degradation products.
Poly(aspartic acid), poly(L-lysine), and poly(γ-glutamic acid) are three amino acid-based polymers
that have been investigated for biomedical applications. Poly(aspartic acid) is a highly watersoluble ionic polymer, synthesized from aspartic acid by thermal polymerization. Poly(γ-glutamic
acid) is also a water-soluble anionic polymer, composed of a mixture of D- and L-glutamic acid
and produced by microbial fermentation. Poly(γ-glutamic acid) is one of the amino acid-based
polymers studied extensively for hybrid material synthesis.122, 165, 166 Poly(L-lysine) is a cationic
polymer based on L-lysine and produced by bacterial fermentation.167, 168
Poly(ester amide) (PEA) is another class of amino-acid derived polymers with both ester and
amide functional groups on their backbone, which combine several properties of polyesters such
as degradability (by hydrolysis of ester groups) and polyamides such as good mechanical and
thermal properties (due to the intermolecular hydrogen bonding of amide groups).167 Amino acidbased PEAs have been investigated for tissue engineering and drug and gene delivery
applications,169-176 while they have never been introduced as the organic component of a hybrid.
These biodegradable polymers are based on α-amino acids, aliphatic diacids, and aliphatic diols.
PEAs can degrade through both hydrolytic and enzymatic mechanisms. The degradation products
include physiological amino acids, which can be easily metabolized in vivo. Moreover, the surface
erosion-like degradation of PEAs limits the accumulation of acidic degradation by-products as
repeatedly seen in polyesters. Therefore, PEAs are well-tolerated in vivo. Different amino acids
and various diacids and diols can be used in the synthesis of PEAs, and functional pendant groups
can also be inserted in the backbone. The degree of crystallinity, the melting and glass transition
temperatures, and the degradation rate can be modulated depending on the amino acid used.177
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Solution polycondensation and interfacial polycondensation are two commonly used approaches
for the synthesis of PEAs. In the solution polycondensation, di-p-toluenesulfonic acid salts of bis(α-amino acid) diesters react with di-p-nitrophenyl esters of diacids.178-180 Aliphatic or aromatic
and saturated or unsaturated 181 PEAs can be synthesized by solution polycondensation depending
on the starting diacid and diol used. However, the production of a large amount of side products
(e.g. p-nitrophenol) necessitates an extensive purification step. In the interfacial polycondensation,
di-p-toluenesulfonic acid salts of bis-(α-amino acid) diesters α,ω-alkylene diesters react with
diacid chlorides. As the name implies the reaction occurs at the interface of an organic phase
containing the diacid chloride and an aqueous phase containing the di-p-toluenesulfonic acid salt
and Na2 CO 3 as a base.182
Comparable to solution polycondensation, interfacial polymerization is faster, less sensitive to
impurities, and can produce higher molecular weight PEAs. The PEA used in this thesis has been
synthesized by interfacial polymerization using L-phenylalanine, sebacoyl chloride, and 1,4butanediol and is named 8-Phe-4 (8 stands for the number of methylene groups of diacid and 4
stands for the number of methylene groups of diol).183

Figure 2.4. Chemical structure of 8-Phe-4 PEA, the green, red and blue boxes show amino acid,
diol, and diacid segments, respectively.
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Using L-phenylalanine as the amino acid increases the hydrophobicity of PEA and subsequently
increases its susceptibility to enzymatic degradation. PEAs show a surface erosion behavior in
enzymatic degradation,184, 185 which is beneficial for maintaining the mechanical integrity of the
tissue engineering scaffolds. The mass loss is reported to be linear, and the molecular weight of
undegraded polymer at any time over the course of degradation is similar to the initial molecular
weight. Moreover, the phenyl group of the amino acid is expected to provide rigidity for the
polymer chains. Previous studies have shown that 8-phe-4 has a glass transition temperature close
to body temperature (39°C), which is beneficial to provide pliability for favorable cell-material
interaction.183 Particles of 8-Phe-4 prepared by oil-in-water emulsion have been used for drug
delivery application.171, 186 PEAs have not been used for bone tissue engineering applications in an
organic-inorganic hybrid. Although 8-Phe-4 is the only PEA used in the current study, different
PEAs synthesized from different amino acids and with various physical and chemical properties
can be introduced and incorporated in a hybrid material to synthesized hybrid biomaterials with
various and tunable properties.

2.7.

Hypothesis and objectives

Hypothesis: Organic-inorganic hybrid materials based on poly(ester amide) and bioactive glasses
in combination with biomolecule delivery serve as bone biomaterials.
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Objectives:
1. Synthesis of an organic-inorganic hybrid material based on poly(ester amide) and bioactive
glass and fabrication of scaffolds thereof in combination with mesoporous silica
nanoparticles as a delivery vector embedded within the scaffold.
2. Synthesis of organic-inorganic hybrid microparticles based on poly(ester amide) and
bioactive glass with the drug loading capacity.
3. In vitro cell studies to evaluate the potential of hybrid microparticles and delivered
compound(s) to direct osteogenic differentiation of cells.
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Chapter 3
3. Poly(ester amide)-Bioactive Glass Hybrid Biomaterials for
Bone Regeneration and Biomolecule Delivery*
Overview: The purpose of the study herein is to synthesize organic-inorganic hybrid biomaterials
based on poly(ester amide) and tertiary bioactive glass using calcium alkoxide as a precursor in
the sol-gel process, while controlling the rate of reaction. The hybrid biomaterial was processed
to fabricate porous scaffolds with incorporated mesoporous silica nanoparticles as a delivery
carrier within the scaffolds.

Scheme 3.1. Graphical abstract of Chapter 3

*This chapter has been published. Reprinted with permission from (Aslankoohi, N. , Mequanint, K.;
Poly(Ester Amide)–Bioactive Glass Hybrid Biomaterials for Bone Regeneration and Biomolecule
Delivery. ACS Appl. Bio Mater. 2020, 3 (6), 3621–3630).

3.1.

Abstract

Designing bioactive materials for repairing or regenerating bone defects is an active area of
research and discovery. Despite advances made in sol−gel-derived hybrid biomaterials design,
three challenges remain: (i) the choice of biodegradable polymers that can form a homogeneous
solution in the presence of water is very limited, (ii) low-temperature (below 50 °C) incorporation
of calcium into the inorganic matrix while having molecular-level mixing has proven to be a
difficult task, and (iii) incorporation of drug-loaded mesoporous nanoparticles into polymerbioactive glass hybrid scaffolds has not been achieved. In this study, bioactive biomaterials for
bone repair/regeneration have been developed from an α-amino acid-derived biodegradable
poly(ester amide) (PEA) and a tertiary bioglass (SiO 2 −CaO−P2 O5 ), where calcium was
incorporated into the glass network at ambient temperature. Furthermore, drug-loaded functional
mesoporous silica nanoparticles prepared by surfactant templating were successfully incorporated
into PEA−bioglass porous scaffolds. The resulting homogenous single-phase materials showed
deposition of hydroxyapatite on their surfaces, supported mesenchymal stem cell attachment and
proliferation, and showed a sustained and slow release of a model compound. Taken together,
these biomaterials have the potential to be used as a bifunctional platform for bone regeneration
via ion release and biomolecule delivery.
Keywords: hybrid biomaterials, bone tissue engineering, sol−gel process, poly(ester amide)s,
tertiary bioactive glass, mesoporous silica nanoparticles.
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3.2.

Introduction

Bone is an organic-inorganic hybrid material on the compositional level with hydroxyapatite as
the inorganic component and mainly collagen as the organic component which has developed a
complex hierarchical architectural structure. 1 Repairing of bone defects caused by fractures, severe
infection, or after tumor resection requires biomaterial-assisted intervention. Taking inspiration
from nature has led to the development of a class of biomaterials, namely, organic-inorganic (O/I)
hybrid biomaterials, which hold great potential for bone tissue engineering and regeneration
applications. These materials exploit the bioactivity and osteogenic nature of inorganic materials
such as bioactive glasses (BG) and their ability to bond to the bone while providing toughness and
processability by introducing a polymer into the glass network and formation of an interpenetrating
network on the nanoscale. The interfacial interaction between the organic and inorganic phases on
the molecular level results in a single-phase material. The substantial influence of calcium ions on
adhesion, proliferation, and differentiation of osteoblasts and its role in signaling cascades for bone
regeneration has been studied extensively.2-8 However, introducing Ca as a component of the BG
network in a hybrid biomaterial is challenging for two reasons. First, if calcium salts such as CaCl2
and Ca(NO 3 )2 9 are used as precursors, high-temperature (ca. 600 °C) treatment is needed for the
Ca to enter the glass network- a process, that is not compatible with the presence of the organic
component. Second, if calcium alkoxides capable of entering the glass network at low temperatures
are used, the high rate of hydrolysis and condensation leads to an inhomogeneous distribution of
organic and inorganic components10 and a very narrow window of operation for processing.
Attainment of a homogeneous single-phase hybrid material is essential for having congruent
properties. Ideally, in a degradable hybrid biomaterial, the two components should degrade at a
comparable rate so the scaffold can be gradually replaced by the newly formed tissue while
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maintaining its structural integrity for a longer time. Poly(ester amide)s (PEA)s are a class of
synthetic polymers based on the natural amino acids. PEA is susceptible to both hydrolytic and
enzymatic degradation mechanisms, and it has been reported that PEA shows surface erosion
behavior in the degradation.11, 12 Therefore, the molecular weight of undegraded polymer at any
time is similar to the initial molecular weight, and the mass loss profile is linear. This can be
beneficial compared to the bulk erosion of many synthetic polymers because of the preservation
of the structural integrity and mechanical stability of the scaffold over the degradation course. 13
The development of a bifunctional biomaterial platform for simultaneous inorganic ion release for
bone regeneration and therapeutic delivery for cell-fate determination is of particular interest and
can be accommodated by the incorporation of a delivery system within the O/I scaffold. O/I hybrid
biomaterials not only mimic the composition of bone but also have the ability to bond to native
bone because of the release of ions from their inorganic component, and also to stimulate cells for
regeneration.4,

5, 7

By combining a drug delivery system with ion releasing bioactive glass, a

bifunctional scaffold could be fabricated. Mesoporous silica nanoparticles (MSNs) are emerging
as a potential drug delivery system to regenerate bone due to their high surface area for high
loading capacity. It has been reported that culturing of human bone marrow stromal cells with
MSNs led to osteogenic differentiation by activation of alkaline phosphatase, osteopontin,
osteocalcin, and runt-related transcription factor 2.14 Silicon ions have shown similar osteogenic
stimulatory effects on murine bone marrow mesenchymal stem cells.15 Different signaling
pathways were investigated to elucidate the osteogenic effect of Si ions.16, 17 In addition, the
versatile silica chemistry brings about the opportunity to tailor the functionality, morphology, and
pore size of nanoparticles for different cargo deliveries. The objectives of the present study were
to: (i) synthesize amine-functionalized MSNs for drug loading, (ii) to develop a homogenous
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organic-inorganic hybrid material using L-phenylalanine-based PEA and tertiary bioactive glass
(SiO 2 -CaO-P2 O5 ), where calcium was incorporated into the glass network at ambient temperature,
and (iii) to fabricate 3D scaffolds from drug-loaded MSN and PEA-bioactive glass as a potential
bifunctional platform for bone tissue engineering and regeneration application (Scheme 3.1).

Scheme 3.2. Schematic Illustration of (A) Synthesis and Functionalization of MSNs and (B)
Synthesis of Hybrid Material and Fabrication of Hybrid Scaffold

3.3.

Materials and Methods

3.3.1. Materials
Tetraethyl orthosilicate (TEOS, 98%), hexadecyltrimethylammonium bromide (CTAB, 98%),
triethyl phosphate (TEP, 99.8%), 3-aminopropyl triethoxysilane (APTES), and fluorescein
isothiocyanate (FITC) were purchased from Sigma-Aldrich (Milwaukee, WI, USA). Calcium
ethoxide was purchased from Gelest Inc. (Morrisville, PA, USA). Dimethylformamide (DMF) and
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2-ethoxyethanol were purchased from Caledon Laboratory Chemicals (Georgetown, ON, Canada).
A PEA, specifically, 8-Phe-4, was synthesized by interfacial polymerization according to a
previous publication.18 In the PEA nomenclature, 8 stands for the number of methylene groups
from the diacid (sebacoyl chloride), Phe is the L-phenylalanine amino acid and 4 stands for the
number of methylene groups from butanediol. Dulbecco’s modified Eagle’s medium (DMEM) and
Hanks’ balanced salt solution (HBSS) were purchased from Gibco Laboratories (Gaithersburg,
MD, USA). Mouse embryo multipotent mesenchymal progenitor cells (C3H/10T1/2 cells) were
purchased from ATCC (Manassas, VA, USA). The CyQuant cell proliferation assay kit was
purchased from Invitrogen (Canada).

3.3.2. Synthesis, Functionalization, and Loading of MSNs with FITC
MSNs were synthesized following a general reported procedure. 19 Briefly, a solution of 5.49 mmol
CTAB in water was prepared. To this solution, NaOH (2 M) was added to have a pH of around
12.4. The mixture was heated to 80 °C and 44.8 mmol TEOS was added dropwise. The mixture
was stirred for 2 h after which the nanoparticles were separated by filtration and washed with water
and methanol to remove unreacted reagents. The nanoparticles were further dried and subsequently
calcined at 600 °C for 6 h to remove the surfactant. The functionalization of MSNs with amine
groups is conducted through a co-condensation approach, in which, alongside TEOS, APTES is
added to the reaction mixture. In the case of functionalized MSNs, instead of calcination,
extraction using an acidic alcohol solution was employed to remove the surfactant. After surfactant
removal, amine-functionalized MSNs were added to a solution of FITC in anhydrous DMF and a
catalytic amount of triethylamine (Caledon Laboratory Chemicals, Georgetown, ON, Canada).
After mixing for 24 h at room temperature (RT), the FITC-conjugated nanoparticles were
separated by centrifugation, washed with DMF, and dried under vacuum at 60 °C. The amount of
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FITC in the washing solution of DMF and during the leaching of NaCl porogen used for scaffold
fabrication in water were measured, and the loading was calculated based on the difference
between the original and the washed amount.

3.3.3. Synthesis of the PEA-Tertiary Bioactive Glass Hybrid
Sol−gel process in the presence of a polymer was conducted to obtain a homogeneous class I hybrid
material. A PEA solution was first prepared by dissolving a known amount of PEA in DMF.
Calcium ethoxide was dissolved separately in 2-ethoxyethanol (EE) (5%) and was added to the
polymer solution (volume ratio of DMF/EE = 1) followed by the addition of TEOS, TEP, deionized
(DI) water, and 1N HCl (HCl/TEOS = 0.22) under vigorous stirring at RT. The final solution had
a pH of ∼7. The ratio of organic to inorganic components is kept at 50 wt % and the bioactive
glass has a molar composition of 70% SiO 2 , 26% CaO, and 4% P2 O 5 . Hydrolysis of alkoxides in
the presence of PEA resulted in a clear solution, which turned into a gel by t he subsequent
condensation reaction. After complete gelation overnight, the product was dried at 60 °C under
vacuum for 24 h.

3.3.4. Fabrication of PEA-BG-MSN Scaffolds
The dried PEA−BG hybrid material was pulverized to fabricate scaffolds by compression molding
and salt leaching. The pulverized hybrid powder, NaCl salt crystals as a porogen (150−250 μm
size and 70 vol % porogen loading) and FITC-loaded MSNs as a delivery vehicle were mixed and
heat pressed (Carver Inc., Wabash, IN) at either 100 °C and 1 MPa for 30 min or 50 °C and 1 MPa
for 60 min using a custom-made stainless steel mold. The samples were removed from the mold
and the NaCl crystals were leached using excess DI water at RT for 20 h while shaking at 120 rpm
(with frequent exchange of water), followed by drying under vacuum at RT for 24 h to obtain the
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porous scaffolds. The leaching time by shaking and frequent water exchange was consistent with
reported times for NaCl.20, 21 The resulting disk-like scaffolds had a diameter of 6 mm and a height
of 2 mm. Nonporous hybrid disks were also fabricated by compression of the PEA-BG hybrid
powder only.

3.3.5. Characterization of MSNs, PEA-BG Hybrid Material, and PEA-BG-MSN
Hybrid Scaffolds
Fourier transform infrared (FTIR) spectra of the samples were recorded on a PerkinElmer FTIR
spectrometer using the transmission mode at a resolution of 4 cm−1 and sample scans of 24. The
morphology of the hybrid scaffolds and MSNs were visualized using scanning electron
microscopy (S-3400N SEM, Hitachi, Japan). Samples are mounted on a sample holder using
carbon tape and then sputter-coated with gold/palladium (K550X sputter coater, Emitech Ltd.,
UK) and scanned at a working distance of 8-10 mm and a constant accelerating voltage of 10 kV.
Transmission electron microscopy (Phillips CM10 TEM) was also used to visualize MSNs at an
accelerating voltage of 80 kV. The homogeneity and elemental distribution of the hybrid were
analyzed using an energy-dispersive X-ray spectroscopy (EDX) detector attached to the S-3400N
SEM. Solid-state 1 H-29 Si cross-polarization magic-angle spinning (MAS) NMR spectra were
acquired using a Varian Infinity Plus 400 NMR spectrometer equipped with a Varian tripleresonance 7.5 mm HXY MAS NMR probe. A variable-amplitude CP pulse sequence, where the
amplitude of the

29 Si

channel pulse was increased linearly during the contact time, and 1H

decoupling using continuous-wave decoupling were utilized. A total of either 2600 (2 ms contact
time) or 4000 scans (9 ms contact time) were accumulated using an 8.0 μs 1 H 90° pulse, a 10 s
recycle delay, a 40 kHz sweep width, and a 6.4 ms acquisition time. The FIDs were processed
using 2 zero-fills plus 50 Hz line broadening. Chemical shift referencing was achieved by setting
56

the high-frequency peak of tetrakis(trimethylsilyl)silane

to -9.8 ppm with respect to

tetramethylsilane (δ(29 Si) of TMS = 0.0 ppm). The following equation was used to calculate the
percent degree of condensation (DC) in the hybrid. 22
Equation 3.1:
2
2
3
2(𝑄𝐶𝑎/𝐻
+ 𝑄2𝐻
) + 3(𝑄𝐶𝑎
+ 𝑄𝐻3 ) + 4𝑄4
𝐷𝐶 (%) = (
) × 100
4
𝑛
where 𝑄𝑀
stands for the intensity of a peak in the 29 Si NMR spectrum attributed to the silicate

species with n bridging oxygen atoms and (4-n) nonbridging oxygen atoms connected to atoms M.
The surface area and pore diameter of MSNs were measured using N 2 adsorption/desorption
measurements in a Micromeritics TriStar II 3020 V1.03. The data were evaluated using the
Brunauer-Emmett-Teller (BET) and Barrett-Joyner-Halenda methods to calculate the surface area
and pore volume/pore size distribution, respectively. Samples are prepared by degassing at 90 °C
overnight at 10 °C/min to remove moisture and other adsorbed species. X-ray diffraction (XRD)
data were collected using an X-ray diffractometer Rigaku Ultima III operating on Cu Kα radiation
with λ = 1.5418 Å at 30 kV and 15 mA. XRD spectra were recorded in the 2θ range of 2-90°, at a
scanning speed of 2° min−1 and scanning width of 0.02°.

3.3.6. In Vitro Bioactivity Evaluation
Disk-shaped nonporous specimens weighing 100 mg were incubated in 10 mL of simulated body
fluid (SBF) solution in a plastic vial placed on an orbital shaker at 120 rpm and 37 °C. Samples
were incubated for 1, 3, and 10 days without SBF refreshing. After each incubation period, the
disks were removed from the SBF solution, rinsed with DI water, and dried under vacuum at RT
for 1 day. High-resolution SEM coupled to EDX was performed using LEO 1540XB SEM
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(Hitachi, Tokyo, Japan) at a constant voltage of 2 kV. The specimen surfaces were coated with 5
nm osmium in an osmium plasma coater (OPC80T, Filgen Inc. Japan) prior to SEM and EDX.
Dried specimens were used for performing XRD and FTIR.

3.3.7. Cell Adhesion and Proliferation
10T1/2 cells were used to investigate the cell adhesion to the hybrid material. Hybrid disk samples
were disinfected by immersion in 70% ethanol for 30 min followed by three washes with HBSS
and seeded subsequently with 10T1/2 cells (cultured in DMEM media containing 5% fetal bovine
serum and 1% penicillin/streptomycin) with a cell density of 1400 cells per mm2 and incubated at
37 °C in 5% CO 2 . After 3 and 7 days, cells were fixed using 4% paraformaldehyde (EMD
Chemicals Inc. Gibbstown, NJ). 4´,6-Diamidino-2-phenylindole (300 nmol in PBS) and AlexaFluor 594 conjugated phalloidin (1:100; Thermo Fisher Scientific) were used to visualize cell
nuclei and F-actin, respectively. Images were taken with a Zeiss LSM 510 confocal microscope
(Zeiss, Canada) equipped with argon/neon as well as a UV laser. To measure 10T1/2 cell
proliferation after 3 and 7 days of culture, hybrid disks were secured in a 24 well plate with grease,
disinfected, and seeded with 100,000 cells per well. 2D control (tissue culture plate) was used
along with hybrid disk samples. The experiments were done in quadruplicate. CyQuant cell
proliferation assay kit was used according to the manufacturer’s protocol and the fluorescence
intensity was measured with a Tecan Infinite M1000 Pro fluorescence plate reader.

3.3.8. In Vitro Release Profile of MSNs Embedded within the Hybrid Scaffold
The scaffolds with embedded MSNs were immersed in PBS at 37 °C and pH of 7.4. At each
defined time point, aliquots were removed and replaced with fresh pre-warmed PBS. The samples
were then analyzed with a UV-vis spectrophotometer (at 490 nm) to measure the concentration of
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the released FITC. The experiments were conducted in triplicate. The FITC release profile of
MSNs alone was also measured in the same manner as a comparison to the scaffolds.

3.3.9. Statistical Analysis
Origin Lab was used for the statistical analysis of the cell proliferation and a standard t-test was
used to compare different samples against the control samples. A value of p < 0.05 was considered
statistically significant.

3.4.

Results

3.4.1. Synthesis and Functionalization of MSNs
Shown collectively in Figure 3.1 are the characterization of MSNs. Amine-functionalized MSNs
had a spherical morphology and an average diameter of 232 ± 14 nm as visualized by SEM and
TEM (Figure 3.1A, B). As measured by gas adsorption-desorption, MSNs having a BET surface
area of 780.4 m2 /g and pore diameter of 3 nm were synthesized (Figure 3.1D). The identity of the
nanoparticles was confirmed by the FTIR analysis (Figure 3.1E). The peak at 964 cm−1 was
attributed to silanol (Si−OH) groups, whereas the peaks at 804 and 1090 cm−1 were due to siloxane
bond (Si−O−Si) bending and asymmetric stretching vibration, respectively. The XRD spectrum of
MSNs exhibited an intense narrow peak at 2θ of 0.8° corresponding to the (100) plane, which
resembles the hexagonal MCM-41 type MSNs (Figure 3.1F). The presence of the amine functional
groups was confirmed through the 29 Si NMR measurement (Figure 3.1C). In the Si NMR spectrum,
Qn peaks seen in the chemical shift range of 80-120 ppm correspond to the resonance of silicon
atoms in siloxane bonds (Q n = Si(OSi)n (OH)4-n , n = 2-4) and Tn peaks seen in the range of 50-80
ppm represent organosiloxane bonds (Tn = RSi(OSi)n (OH)3-n , n = 1-3). Therefore, the presence of
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Q peaks confirmed the identity of nanoparticles, whereas T peaks proved the existence of a
covalent linkage between the amine functional groups and the silica network.

Figure 3.1. Characterization of amine-functionalized MSNs. (A) SEM, (B) TEM images of
spherical amine-functionalized MSNs, (C) 29 Si NMR spectra of MSNs showing the presence of Tn
peaks for functionalized MSNs compared to unfunctionalized MSNs, (D) pore size distribution of
MSN (inset: gas adsorption-desorption isotherm), (E) FTIR, and (F) XRD spectra of MSNs.

3.4.2. Synthesis of the Class I PEA-Tertiary Bioactive Glass Hybrid
Hydrolysis of alkoxide precursors occurred by the addition of water and a clear sol was obtained.
The viscosity of the sol progressively increased until it resulted in a viscous gel within 2-3 h. The
condensation reaction continued overnight and after drying of the hybrid material, the obtained
powder was used for further characterization. Figure 3.2A shows the FTIR spectra of the PEA, BG
(synthesized under the same conditions of the hybrid but without the addition of the PEA), and the
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hybrid material. The FTIR spectra of the BG and hybrid showed peaks at 804 and 1030 cm−1
associated with bending and asymmetric stretching of siloxane bonds, respectively. The peak at
448 cm− 1 was attributed to the rocking vibration of siloxane bonds.23 The shoulder peak at 900 cm
−1

corresponded to Si−O nonbridging oxygen bonds which implied the incorporation of calcium

and the formation of Si−O−Ca 24, 25 (shown with the vertical dashed line in Figure 3.2A). The peak
at 674 cm− 1 (turn to a shoulder peak in the hybrid’s spectrum) was assigned to the Ca−O bonds
(shown with the vertical dashed line in Figure 3.2A). In the FTIR spectra of the PEA and hybrid,
the methylene groups (CH 2 ) symmetric and asymmetric stretching, rocking, and wagging
vibrations were observed at 2850, 2920, 700, and 1343 cm− 1 , respectively. The peak at 3300 cm−1
corresponded to amide A N−H bond stretching vibration, whereas the peak at 1530 cm−1
corresponded to amide II N−H bond bending. The carbonyl (C=O) characteristic peaks could be
seen at 1740 cm− 1 (ester C=O) and 1650 cm− 1 (amide I). The peak at 1170 cm− 1 corresponded to C
−O asymmetric stretching and peaks in the range of 1230-1330 cm− 1 were attributed to amide III
vibration, which is related to N−H in-plane bending and C−N stretching. The peaks in the range of
625-770 cm− 1 , called amide IV, were mainly due to O=C−N deformation and the peak at 3050 cm
−1

, amide B, resulted from intermolecular hydrogen-bonded amides.26-28 In the FTIR spectrum of

BG, no peak related to CH 2 was detected therefore, it shows that although the gelation is
accelerated because of the presence of calcium ethoxide, TEOS and TEP seem to have also been
completely hydrolyzed during the sol-gel reaction. Figure 3.2B shows the XRD spectra of PEA,
BG and the PEA-BG hybrids. The pure BG spectrum without any detected peak implied the
amorphous nature of the glass network. In contrast, several peaks were detected in the PEA
spectrum indicating the semi-crystalline nature of the polymer. On the other hand, the diffraction
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pattern of the hybrid showed only two peaks from PEA with diminished intensities indicating that
the hybrid material is mostly amorphous despite the semi-crystalline structure of PEA. The
reduced crystallinity of the PEA in the hybrid was attributed to the confined movement of the
polymer chains in the glass network.29 The same phenomenon has been observed in the PCL/BG
hybrid system, in which hybrids with 10-60 wt % PCL showed no crystallinity despite the semicrystalline structure of pure PCL.30 Restriction of PEA chain mobility leads to the suppression of
its crystallization in the hybrid. Therefore, macromolecular chains confined in the glass network
remained amorphous. The two low-intensity peaks detected can be attributed to those polymer
chains which have more mobility because of less spatial constrains and interfacial interactions with
the glass network.
The

29 Si

NMR spectra of the hybrid shown in Figure 3.2C demonstrated the distribution of Qn

peaks in the glass network. Q n stands for silicate species with n bridging oxygen atoms and (4-n)
nonbridging oxygen atoms. The nonbridging oxygen atoms stem from the presence of silanol (Si
−OH) groups or network modifier atoms, in this case, calcium atoms incorporated in the glass
network. The spectra were acquired with two contact times of 2 and 9 ms. As can be seen from the
intensity of the deconvoluted peaks, for a longer contact time of 9 ms the resonance of Si units far
from hydrogen atoms was enhanced while for a shorter contact time of 2 ms, the signal of silanol
groups was amplified. The five partially overlapping peaks after deconvolution of the spectrum
using MNOVA software were assigned to different species according to their chemical shifts. 31, 32
Peaks located at -110.0, -100.5, -94.5, -90.4, and -83.5 ppm were attributed to Q4 , Q H3 , QCa3, Q2H2,
and Q Ca/H2 , respectively. The presence of two peaks of Q Ca3 and Q Ca/H2 confirmed the incorporation
of calcium atoms within the glass network of the hybrid. The percent DC of the bioactive glass
network in the hybrid calculated using equation 3.1 was 82%.
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Figure 3.2. Characterization of the PEA-BG hybrid. (A) FTIR and (B) XRD spectra of the hybrid
and its organic and inorganic components, (C)

29 Si

NMR spectra of the hybrid (green line) with

two different contact time of 2 and 9 ms showing the distribution of silicate species in the hybrid
(five underlying peaks with distinct shifts as listed in the table) and the total fit (pink line).

3.4.3. In Vitro Bioactivity Evaluation
Hydroxyapatite-like (HA) deposition on the surface of biomaterials following incubation in SBF,
with an ionic composition similar to human blood plasma, is a standard test for the evaluation of
in vitro bioactivity.33 The initial smooth surface of the disk samples was covered with the sphericalshaped particles of hydroxyapatite after incubation in SBF for one day, which revealed the needlelike crystals of hydroxyapatite under high magnifications (Figure 3.3A). Comparing the EDX
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elemental spectra of the hybrid at 0 and 1 day demonstrated the deposition of a Ca- and P-rich
layer evidenced by the increase of the intensity of these elements and the decrease of the intensity
of Si (Figure 3.3B). By incubation for longer times, the surface of the hybrid was completely
covered with a dense layer of hydroxyapatite-like crystals. The quantitative EDX data showed a
Ca/P ratio of 1.68 ± 0.06 for samples incubated in SBF for 1 day. Samples incubated for a longer
time of up to 10 days showed a higher Ca/P ratio of 1.77 ± 0.08, which is slightly higher than the
stoichiometric ratio of hydroxyapatite of 1.67, probably due to carbonate ion substitution in the
hydroxyapatite structure.34 Figure 3.3C shows the XRD spectra of the hybrid material after
incubation in SBF solution for 1, 3, and 10 days. The diffraction peaks at 2θ = 21.8, 25.9, 31.6,
and 45.4° corresponding to (200), (002), (211), and (203) diffraction planes were detected. 35 With
longer incubation time, these peaks became more evident and sharper showing the evolution of
hydroxyapatite. The additional peak at 2θ = 29.4° might correspond to calcite, a polymorph of
calcium carbonate. The FTIR spectra of incubated samples (Figure 3.3D) showed a peak at 964
cm− 1 attributed to the symmetric stretching of P−O bonds in the apatite structure.36 Other known
peaks of hydroxyapatite overlapped with the peaks of the material itself and, therefore, could not
be referred explicitly.
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Figure 3.3. In vitro bioactivity of PEA-BG hybrid biomaterials. (A) SEM images of the surface
of hybrid disk before and after incubation in SBF for 1 and 10 days, (B) EDX elemental spectra of
the hybrid before incubation in SBF (0 day) and after incubation for 1 day and 10 days, (C) XRD
spectra, and (D) FTIR spectra of the hybrid incubated in SBF for 1, 3, and 10 days.
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3.4.4. Morphology and Homogeneity of PEA-BG-MSN Scaffolds
Incorporation of calcium in the inorganic component of the hybrid at low-temperature synthesis
was confirmed with the
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NMR. However, as stated in the Introduction, although the use of

calcium alkoxide precursors brings about the opportunity of incorporation of calcium in the glass
network under low-temperature reaction conditions, the uncontrolled gelation which might result
in an inhomogeneous distribution of organic and inorganic phases, limits their practical
application. Obtaining a visually clear sol after hydrolysis in our system showed that there were
no macroscopic inhomogeneity or phase separation. However, even in a clear sol, there may be
phase separation but undetectable visually. EDX technique was used to map the elemental
distribution of the hybrid material. Figure 3.4 shows the SEM images and the elemental mapping
of a hybrid scaffolds. From SEM images under different magnifications (Figure 3.4A1−A3), the
scaffolds had uniformly distributed and open pores with excellent pore-interconnectivity. The
pores had an average size of 200 μm which is within the range of the porogen size used to create
them. This pore size and a porosity of 70 vol % based on the porogen loading are consistent with
our previous reports using this fabrication process.37 The silicon, phosphorous, and calcium atoms
as components of the tertiary bioactive glass and carbon representing the PEA, all showed uniform
distribution in the hybrid structure. The homogeneity of the hybrid observed by elemental mapping
of the as-synthesized hybrid (data not shown) and the hybrid scaffold after compression molding
and salt leaching (Figure 3.4B2(i−iv)) showed that even after processing of the hybrid to fabricate
3D porous scaffolds the hybrid material maintained homogeneity. The NaCl leaching process did
not affect the calcium distribution (data not shown).
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Figure 3.4. Morphology, pore size, and elemental homogeneity in PEA-BG-MSN scaffolds.
(A1−B2) SEM images of the PEA-BG-MSN hybrid scaffolds under different magnifications (40×,
110×, 120×); (B2(i−iv)) EDX elemental mapping of hybrid scaffolds showing the homogeneous
distribution of the organic and inorganic components of the hybrid (Si, Ca, and P are representative
of SiO 2 , CaO, and P2 O5 , respectively, and C represents the carbon from PEA).

3.4.5. Mesenchymal Multipotent Progenitor Cell Attachment, Spreading, and
Growth
Cell adhesion and spreading on the surface of a biomaterial are essential prerequisites for
subsequent cell proliferation and differentiation. Figure 3.5A, B shows the fluorescent imaging of
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the 10T1/2 cells cultured on the surface of hybrid disks for 3 and 7 days. As can be seen in the
images, the cells formed a uniform dense layer on the hybrid, spreading with a stretched
morphology. The dense layer of elongated cells adhered to the surface of the material suggested
favorable cell-material interactions. The choice of murine mesenchymal multipotent progenitor
cells was based on reported studies on their osteogenic differentiation potential. 38 Cell proliferation
was measured by DNA quantification using CyQuant cell proliferation assay (Figure 3.5C). After
3 days of culture on the hybrid disk, cell proliferation increased significantly comparable to 3 days
of culture on the tissue culture plate. Therefore, the hybrid material not only promoted cell
adhesion but also promoted their proliferation. While the normalized proliferation at 3 days was
significantly higher than the control tissue culture plate (p < 0.05), these cells grew similar to the
control after 7 days of culture. These data suggest that PEA-BG hybrid materials were comparable
to conventional tissue culture plates in terms of supporting cell growth.

Figure 3.5. 10T1/2 cell attachment, spreading, and proliferation of PEA-BG hybrids. Confocal
images of cells after (A) 3 days of culture (B) 7 days of culture (C) DNA quantification normalized
to control cells cultured on 24 wells plate for the indicated times (n = 4 for 3 days and n = 3 for 7
days, *p < 0.05).
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3.4.6. In Vitro FITC Release from MSNs Embedded within the Hybrid Scaffold
The incorporation of MSNs within the scaffold provid es the possibility of enhancement of cell
infiltration and tissue regeneration by the release of biomolecules such as chemotactic agents and
osteogenic factors, prevention of bone infection in the defect site by release of antibacterial agents,
or inhibition of cancer recurrence after tumor removal by the release of chemotherapeutic agents.
Here, FITC, as a model drug has been conjugated to amine-functionalized MSNs and its release
profile, has been investigated (Figure 3.6). Isothiocyanates react with amine groups and form
thiourea linkages between FITC molecules and MSNs. FITC-loaded MSNs showed an
encapsulation efficiency of 75% after embedment in the hybrid scaffold and removal of NaCl
porogen. A slow release was observed with 45% cumulative release after 20 days. Conjugation of
FITC to amine functional groups in the MSNs and incorporation of MSNs within the scaffold not
only reduced the release rate but also mitigated the initial burst release. Comparable to the scaffold,
functionalized MSNs alone showed a cumulative release of 64% after 20 days. However, it was
shown that FITC loaded passively in the unfunctionalized MSNs has a fast release profile of more
than 75% in 50 h.39
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Figure 3.6. Release profile of FITC as a model compound from MSNs alone or embedded within
PEA-BG hybrid scaffolds. Data are mean ± SD for n = 3 measured in PBS at 37 °C. Note that the
error bars are too small to be visible on the plots.

3.5.

Discussion

Organic-inorganic hybrid biomaterials are one of the most promising class of materials for bone
tissue engineering. The rationale for hybrid biomaterials is to recapitulate the native bone
composition to which these materials are intended to replace. Contrary to conventional two-phase
composites, the organic and inorganic phases of hybrid materials are indistinguishable on the
nanoscale. In this study, first amine-functionalized MSNs were synthesized and loaded by
conjugation of a model compound to the functional groups. Then homogeneous and single-phase
organic-inorganic hybrid materials were prepared using PEA and tertiary bioactive glass. Finally,
the nanoparticles were incorporated into the hybrid materials to fabricate PEA-BG-MSN scaffolds.
Many natural and synthetic polymers have been used as an organic component to prepare hybrid
biomaterials.40, 41 However, this is the first study on the incorporation of PEAs into the sol-gel
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process for the preparation of hybrid biomaterials. PEA is a class of synthetic polymers based on
natural amino acids and has been studied as polymeric scaffolds for tissue engineering and
polymeric carriers for drug delivery applications. 42, 43 Sol-gel chemistry is normally carried out
using water as the main solvent and, therefore, limited to the use of water-soluble polymers. The
use of water-miscible organic solvents30, 44 or nonaqueous sol-gel process45 is an effort to expand
the options available for polymer incorporation into hybrid biomaterials. In the current study, a
water-insoluble PEA was introduced into the sol-gel process using a water-miscible co-solvent.
There are at least three advantages of using PEA compared to the commonly used
polycaprolactone, namely: (i) the chemical compositions of the amino acid -based PEAs are
analogous to peptides and proteins; (ii) the PEAs can be designed to degrade at a desired rate as
different amino acids can be incorporated;46 and (iii) the byproducts following degradation of these
PEAs will include amino acids, which are found physiologically, limiting their potential toxicity.18
The PEA specifically used in this study was synthesized from L-phenylalanine and was chosen due
to several reasons. Previous studies have shown that 8-Phe-4 has a glass transition temperature
(Tg) of 39 °C, which is expected to be lower in physiological conditions because of the plasticizing
effect of water. This low Tg can provide the PEA with pliability under physiologically relevant
forces, which is beneficial for the interaction with cells.18 In addition, the phenyl group in the
structure of PEA gives it rigidity and possibly improves the mechanical properties compared to
other PEAs synthesized with linear amino acid residues. Moreover, its hydrophobicity balances
the enzymatic and hydrolytic degradation leading to a surface erosion behavior. 26 Therefore, the
integrity of the porous scaffolds can be potentially maintained over the course of degradation. The
current study also paves the way for the incorporation of other types of PEAs based on different
amino acids and with different physical and chemical properties.
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In addition to the organic component, the inclusion of calcium in the hybrids, which is essential
for bioactivity and osteogenicity, has always been challenging and stems from the absence of an
appropriate calcium precursor for the inclusion of calcium in the inorganic network at low
temperatures. As a result, many organic-inorganic hybrid systems lacked calcium oxide as a
component of the inorganic phase. In addition, if calcium ions are introduced in the hybrid but not
incorporated in the glass network, the elevated concentration of calcium ions because of the burst
release of ions upon contact with a biological fluid, not only leads to an abrupt increase of the local
pH but also causes cytotoxic effects.6 Calcium alkoxides are potential candidate precursors for
hybrid material synthesis by a sol-gel process at low temperatures. The use of calcium alkoxides
results in a pH increase and subsequently increases the gelation rate of the sol.22 The formation of
an ionic Si−O−Ca+ bond can occur through two mechanisms: (i) reaction of deprotonated silanols
and Ca2+ ions (SN1 mechanism) and (ii) reaction of deprotonated silanols and undissociated
calcium alkoxide (SN2 mechanism).22 In this study, calcium was incorporated in the glass network
at low temperatures using calcium ethoxide as demonstrated by
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NMR (Figure 3.2C).

Compared to other calcium alkoxides used in previous studies (e.g., calcium methoxyethoxide), 47,
48

calcium ethoxide is less toxic because of the generation of ethanol as a byproduct or as residual

ligand in the case of incomplete hydrolysis of the alkoxide, compared to methanol and
methoxyethanol. Furthermore, unlike other uncontrollably fast 10, 48 synthesis procedures in the
presence of a calcium alkoxide (due to the pH increase as a result of introducing calcium
ethoxide),22 the hydrolysis and gelation in the current work took about 3 h in a controlled manner
resulting in a reasonable window of operation for the processing of the hybrid material.
Furthermore, it was observed that the reaction time can be modulated by adjusting the amount of
water and acid catalyst.
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Homogeneity is another issue in hybrid materials because the organic and inorganic phases are
often incompatible. Moreover, the high reactivity of calcium alkoxides makes the formation of
homogeneous hybrids very challenging.48 Homogeneity is important in the case of cell-material
interaction as the surface immediately presented to the cell might be a hydrophobic polymer solely
in an inhomogeneous hybrid. Furthermore, inhomogeneity might result in an incongruent
degradation of the hybrid scaffold. EDX analyses showed the uniformity of both the as-synthesized
hybrid material and the processed hybrid in the form of a porous scaffold (Figure 3.4). In addition,
the disappearance of several PEA crystalline peaks in the XRD spectrum of the hybrid further
demonstrated the distribution of PEA chains in the glass network on the molecular level, which
subsequently inhibited the crystallization of the PEA. 29 Therefore, the hybrid material is expected
to show congruent physical and chemical properties.
Delivering both stimulatory ions (from the inorganic part) and biomolecules (loaded to the MSN)
is the employed strategy in order to prepare bifunctional scaffold systems. In addition to delivering
biomolecules, MSNs also release silicon ions through their gradual degradation. MSN synthesis is
conducted using the sol−gel process similar to BG and because of their similar chemistry as the
inorganic component of the hybrid, they can be easily incorporated into the scaffold. Release of
bioactive factors from MSNs could improve the efficacy of bone regeneration by modifying the
microenvironment of the scaffold, for instance, by delivering agents promoting angiogenesis or
cell differentiation. Moreover, it can be utilized as a tool to address complications exacerbating
bone defects such as bone infections and cancer recurrence after tumor resection. In the present
study, conjugation of the FITC as a model compound to amine-functionalized MSNs and their
embedment within the scaffold slowed down the release rate and provided a sustained release
profile for a duration of 3 weeks (Figure 3.6). FITC was chosen because it reacts with the amine
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functional groups of the MSN and also because it is relatively hydrophobic which allows us to
leach the NaCl porogen from the MSN-embedded scaffolds using water without significantly
affecting the drug loading efficiency (75% overall efficiency was achieved). Incorporation of
hydrophobic drugs (e.g., the anti-inflammatory indomethacin, Mw = 358 g/mol, osteogenetic
stimulator dexamethasone Mw = 390 g/mol, and possibly GSK3β inhibitors) is also envisioned into
the scaffolds.49 FITC with a Mw of 389 g/mol has a similar size to these and other hydrophobic
osteogenic compounds. Depending on the thermal sensitivity of the loaded compound in the
MSNs, the compression molding temperature for the fabrication of the scaffold can be decreased
by increasing the compression time (e.g., 50 °C and 1 MPa for 1 h). Apart from the silicon ion
released from MSNs, silicon, calcium, and phosphorus ions are also released from the hybrid
scaffold, which contribute to the deposition of hydroxyapatite on the surface of the scaffold as
evidenced by FTIR, SEM-EDX, and XRD (Figure 3.3). The deposited hydroxyapatite is expected
to promote bonding of the scaffold to the bone in vivo.50 Moreover, these released ions from BG
present stimulatory effects on cells.4, 5 Therefore, the current hybrid scaffolds with an embedded
delivery system may provide the bifunctionality of bone regeneration and biomolecule delivery
and could serve as a platform for the development of other systems. Different biomolecules can
be loaded in the MSNs with tailorable pore sizes or different types of PEAs can be used as the
organic component of the hybrid. Adhesion and proliferation of 10T1/2 cells to the surface of the
hybrid and formation of a dense layer of cells demonstrated the favorable interaction of cells and
hybrid.
The main aim of this study was the preparation of MSN and polymer-bioactive glass hybrid
biomaterials and their structural and morphological characterization, bioactivity, cell-interactions,
and model drug release studies. The current biomaterials are not intended for load -bearing

74

implants; however, they are envisioned to be used as: (i) cell-guiding biodegradable templates that
stimulate bone regeneration in vivo and in vitro while remodeled by cells and (ii) drug delivery
vehicles through drug-loaded MSN incorporation to the template scaffolds. Thus, their mechanical
properties are expected to continuously change in vivo or under bioreactor conditions. Because of
these reasons, the mechanical properties were not investigated in this study. Nonetheless,
acceptable initial mechanical properties may still be useful and will be investigated in future
studies.

3.6.

Conclusions

In this study, the PEA-BG hybrid material were synthesized via the sol-gel process and fabricated
a 3D porous scaffold in combination with MSNs for bone tissue engineering application. PEA was
introduced in the inorganic network during its formation and a single-phase homogeneous hybrid
material was obtained. The bioactivity of the hybrid was confirmed by the formation of
hydroxyapatite after 24 h of incubation in SBF as evidenced by FTIR, XRD, and SEM-EDX. The
cytocompatibility of the hybrid was demonstrated by adhesion and proliferation of mouse embryo
multipotent mesenchymal progenitor cells cultured for 3 and 7 days on the surface of hybrid disks.
MSNs embedded in the hybrid scaffold showed a slow release profile with 45% cumulative release
after 20 days. Taken together, the bifunctional hybrid scaffold has the potential to be used as a
platform for simultaneous bone regeneration and therapy.

3.7.
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Chapter 4
4. Intrinsically Fluorescent Bioactive glass-Poly(ester amide)
Hybrid Microparticles for Dual Drug Delivery and Bone
Repair*
Overview: The purpose of the study herein is to synthesize organic-inorganic hybrid
microparticles based on poly(ester amide) and bioactive glass under acidic sol-gel process. The
homogeneity and bioactivity of microparticles were studied. In addition, the potential of hybrid
microparticles to act as a delivery vector was evaluated. Preliminary results on the
osteoconductivity of the microparticles and their incorporation in 3D cell-embedded fibrin
hydrogels were also reported.

Scheme 4.1. Graphical abstract of Chapter 4
*This chapter has been published. Reprinted with permission from (Aslankoohi, N.; Mequanint, K.,
Intrinsically fluorescent bioactive glass-poly(ester amide) hybrid microparticles for dual drug delivery and
bone repair. Materials Science and Engineering: C 2021, 128, 112288).

4.1.

Abstract

The bone extracellular matrix (ECM) is a composite scaffold having inorganic hydroxyapatite and
organic collagen fibers. Synthetic bone repair scaffolds that mimic the chemical composition of
the native ECM and capable of delivering therapeutics are beneficial. In this study, intrinsically
fluorescent organic-inorganic hybrid microparticle biomaterials were prepared by sol-gel process.
Unlike the conventional Stöber process which requires an alkaline condition for microparticle
formation, an acidic condition in the presence of a biodegradable poly(ester amide) (PEA) polymer
was used to prepare silica and tertiary bioactive glass hybrids. During their preparation, one or two
model drugs were loaded in the microparticles. Our results showed that a gelation temperature
between 40°C-60°C and the inclusion of PEA were critical for microparticle formation.
Unexpectedly, the hybrid microparticles were fluorescent with tunable emission by changing the
excitation wavelengths ranging from 300 to 565 nm for potential multiplex imaging. Gene
expression studies showed that the hybrid materials induce osteogenic differentiation of 10T1/2
cells without adding exogenous biochemical factors. The bioactivity of the inorganic phase and
the dual drug release from homogenous, biodegradable, biocompatible, osteoinductive, and
intrinsically fluorescent microparticles may offer a unique platform for bone regeneration and
therapy.
Keywords: Fluorescent hybrid microparticles, Sol-gel process, Poly(ester amide)s, Bioactive
glass, Dual drug delivery, Osteogenic differentiation.
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4.2.

Introduction

Biomaterials designed for bone repair and regeneration are expected to mimic some properties of
the natural bone extracellular matrix (ECM) which is a highly calcified collagen matrix. Because
of the presence of both collagen fiber and hydroxyapatite minerals, an ideal bone biomaterial is
better designed considering these two components. Advances made in sol-gel chemistry allow a
low-temperature process by which a natural or synthetic degradable polymer could be combined
with bioactive glasses to mimic the composition of bone ECM. Moreover, the presence of both a
polymer and an inorganic part can enhance the functionality of the material and its contribution to
tissue regeneration through modified cellular interaction and improved mechanical properties.1, 2
In a properly designed polymer-bioactive glass system, the organic and inorganic components
form an interpenetrating network with uniform elemental distribution throughout the matrix,
leading to a single-phase material at the nanoscale.

3

Previous studies have reported the utility of

sol-gel-derived polymer-bioactive glass biomaterials in the form of porous scaffolds,4 electrospun
fibers,5 and monolith structures6 for potential bone repair and bone tissue engineering applications.
Nano- and micro-particles of silica and bioactive glasses have also been actively investigated for
bone tissue regeneration since they provide a higher surface area, which enhances the bioactivity
and makes the particles better candidates for incorporation into polymeric matrices.7 Moreover, it
broadens the utility of particles as a drug delivery carrier or an injectable system. From a synthetic
perspective, the Stöber process, in which the sol-gel process occurs under highly basic conditions,
is the primary approach to prepare both inorganic and polymer-silica microparticles by the
introduction of the polymer into the sol-gel process in an emulsion setting.8, 9 Although there have
been attempts at polymer incorporation in the sol-gel process and the formation of particles under
acidic conditions, only water-soluble polymers10-12 or amphiphilic block copolymers13 were used.
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In addition, the polymers used in these cited studies were used as a template and had been removed
by dissolution or calcination after the microparticle preparation.
In this study, intrinsically fluorescent and homogeneous polymer-inorganic hybrid microparticles
have been prepared from L-phenylalanine-based poly(ester amide) (PEA) and either silica (SiO 2 )
or tertiary bioactive glass (SiO 2 -CaCl2 -P2 O 5 ) as the inorganic constituent of the hybrid
microparticles. This approach is contrary to the well-known Stöber process. To the best of our
knowledge, there is no prior report on the formation of single-phase homogeneous hybrid
microparticles synthesized using a water-insoluble biodegradable polymer and sol-gel reaction
under acidic conditions. The synthesis process introduced here is convenient and can be adopted
for different polymers. In addition, one or two active agents can be loaded in the microparticles
during the synthesis process (Scheme 4.2). Furthermore, PEA has intrinsic fluorescence, and its
presence endows microparticles with the fluorescent property without external fluorophores.

Scheme 4.2. Schematic illustration of the two-stage synthesis approach of PEA-bioactive glass
hybrid microparticles. Two different active agents can be loaded in the microparticles during
synthesis by addition to each phase, as shown in the brackets.
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4.3.

Materials and methods

4.3.1. Materials
Tetraethyl orthosilicate (TEOS, 98%), triethyl phosphate (TEP, 99.8%), polycaprolactone (PCL;
̅𝑛 = 80 kDa), Nile blue A, and rhodamine 123 were purchased from Sigma-Aldrich (Milwaukee,
𝑀
WI). Dimethylformamide (DMF) was purchased from Caledon Laboratory Chemicals
(Georgetown, ON, Canada). Methyl ethyl ketone (MEK) and calcium chloride dihydrate were
purchased from Fisher Scientific. Citric acid was purchased from Omnipur®. PEA was
synthesized by interfacial polymerization using sebacoyl chloride, butanediol, and LPhenylalanine as the amino acid according to our previous publication.14

4.3.2. Synthesis of organic-inorganic hybrid microparticles
A PEA solution was first prepared in DMF and MEK (MEK:DMF = 1:2). Three weight ratios of
the PEA to the inorganic components (2:3, 1:1, and 3:2) were investigated. The inorganic
components studied were silica (SiO 2 ), binary (SiO 2 -P2 O5 ), and tertiary (SiO 2 -CaCl2 -P2 O5)
bioactive glass. The microparticles were prepared either in a single-stage or two-stage approach.
In the single-stage approach, the PEA solution, the inorganic precursors, water, ethanol, and
catalytic HCl were mixed at room temperature (RT) and heated to different temperatures (40 °C100 °C) for gelation to occur. In the two-stage approach, the inorganic sol was prepared separately
at RT over 18 h while mixing. The sol was then added to the PEA solution and kept at different
temperatures until gelation. In both approaches, the final samples were dried in a vacuum at 60 °C
to obtain a fine white powder. When PCL was used instead of PEA as the polymer component, the
same procedures were used, except the dissolution of PCL was carried out at 35 °C instead of RT.
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4.3.3. Characterization of hybrid microparticles
The morphology, homogeneity, and elemental distribution of the hybrid microparticles were
visualized using scanning electron microscopy (S-3400N SEM, Hitachi, Japan) and energydispersive X-ray spectroscopy (EDX) with an accelerating voltage of 10 kV and a working
distance of 8-10 mm. The average size of PEA-SiO 2 microparticles was measured using SEM
images and ImageJ software. FTIR spectra of the samples were recorded on a PerkinElmer FT-IR
Spectrometer at a resolution of 4 cm-1 . X-ray diffractometer Rigaku Ultima III operating on Cu Kα
radiation (λ = 1.5418 Å) was used to collect X-ray diffraction (XRD) pattern in the 2θ range of 2°
to 90° with a scanning width of 0.02° and a scanning speed of 2°/min. The molecular weight of
PEA extracted from dried microparticles was measured by gel permeation chromatography (GPC)
using the Wyatt miniDAWN Treos Light Scattering detector and a Wyatt Optilab Rex RI detector
operating at 658 nm. Polystyrene was used as a calibration standard. The intrinsic fluorescence of
the hybrid microparticles was evaluated by a Compound Fluorescence Zeiss Z1 Microscope (Zeiss,
Canada) at different wavelengths.

4.3.4. In vitro bioactivity and degradation evaluation
The fluorescent PEA-BG (BG composition: 85% SiO 2 -10% CaCl2 -5% P2 O5 ) hybrid microparticles
and PEA films were incubated in simulated body fluid (SBF) at 37 °C for 1 and 3 days under
constant shaking at 120 rpm. After the incubation period, the samples were rinsed with absolute
ethanol and dried under vacuum at RT. The specimen surfaces were visualized by SEM-EDX
using LEO 1540XB SEM (Hitachi, Tokyo, Japan). Dried microparticles were used for conducting
XRD studies. To evaluate degradability, disks (6 mm diameter and 2 mm height) were prepared
from the microparticles using compression molding in a custom-made stainless-steel mold (1 MPa,
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100 ◦C, 15 min). The disks were incubated in phosphate-buffered saline (PBS) at 37 °C with
shaking at 120 rpm while PBS was replaced every three days for up to 28 days of study. The mass
loss was calculated from the difference between the initial and final mass of the samples. The
experiments were conducted in triplicate.

4.3.5. In vitro release profiles of model compounds loaded in the hybrid
microparticles
Nile blue A as a relatively hydrophobic model drug was added to the polymer solution, while
rhodamine 123 was added to the inorganic sol during the microparticle preparation. Release studies
were conducted at 37 °C in PBS containing 30% EtOH, due to the insolubility of Nile blue in PBS.
At each defined time point, aliquots were removed and replaced with a fresh pre-warmed release
medium. The removed samples were analyzed with UV-VIS spectrophotometer at 639 nm and 505
nm to measure the concentration of the released Nile blue and rhodamine 123, respectively.
Vierordt's method was utilized to calculate the concentration of each compound from the
absorbance of the mixture. The experiments were conducted in triplicate.

4.3.6. Cell culture studies with hybrid microparticles and osteogenic gene
expression
Embryonic multipotent mesenchymal-like progenitor cell line (10T1/2 cells) (ATCC) were
cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Thermo Fisher) containing 5% Fetal
Bovine Serum (FBS) (Thermo Fisher) and 1% penicillin/streptomycin. Cells were seeded in a 24well plate with a seeding density of 5 × 10 4 per well. After reaching confluency, the cell culture
media was aspirated and replaced with either media containing 5 mg/mL PEA-BG microparticles,
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disinfected by exposure to UV light for 10 min (BG composition: 70% SiO 2 -10% CaCl2 -20%
P2 O 5 ), or osteogenic media (Day 0). Cells cultured with DMEM media were used as control. The
osteogenic media contained 10-7 M dexamethasone, 50 μg/mL ascorbic acid, and 3 mM Na x H3x PO 4 .

The medium was changed every 3 days. After a pre-determined time, total RNA was

extracted using Trizol (Thermo Fisher) following the manufacturer's protocol. Complementary
DNA (cDNA) template was prepared by using 1 μg of total RNA primed with random primers
according to Promega™ Random Hexamers protocol (Thermo Fisher). qPCR was carried out in
10 μL of reaction volumes, using a CFX96™ Real-Time System (C1000 Touch Thermal Cycler,
Bio-Rad, Canada) and then measured with iQ™ SYBR® Green Supermix (Bio-Rad) according to
the recommended protocol by the manufacturer. The sequences of primers were designed using
Primer3Web and are presented in Table 4.1. Primers for mouse-specific mRNA amplification. The
results were analyzed with the comparative threshold cycle method and normalized with GAPDH
as an endogenous reference and reported as relative values (ΔΔ CT) to the control.
Table 4.1. Primers for mouse-specific mRNA amplification.
Gene

Forward primer (5´→ 3´)

Reverse primer (5´→ 3´)

Runx2

CACTGGGTCACACGTATGATT

AGGGAAGGGTTGGTTAGTACA

Alpl

CCTTCACGGCCATCCTATATG

CTGGTAGTTGTTGTGAGCGTA

Spp1

ATCTCACCATTCGGATGAGTCT

TGTAGGGACGATTGGAGTGAAA

GAPDH

GGTGGTCTCCTCTGACTTCAACA GTTGCTGTAGCCAAATTCGTTGT

Runx2 - Runt-related transcription factor 2; Alpl - Alkaline phosphatase; Spp1 - Osteopontin.
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4.3.7. 10T1/2 cells adhesion to hybrid microparticles and incorporation of
microparticles in fibrin gels containing 10T1/2 cells
To investigate adhesion of cells to the hybrid microparticles, PEA-BG microparticles (BG
composition: 85% SiO 2 -10% CaCl2 -5% P2 O 5 ) were compressed to form disk specimens as
described in Section 4.3.4. Hybrid disks were disinfected by immersion in 70% ethanol for 30 min
followed by two washes with HBSS and subsequently seeded with 10T1/2 cells (35,000 cells/cm2 ).
After 24 h, cells were fixed using 4% paraformaldehyde (EMD Chemicals Inc. Gibbstown, NJ)
and stained with Alexa-Fluor 568 conjugated phalloidin (1:100; Thermo Fisher) to visualize Factin and counterstained with 4′ ,6-Diamidino-2-phenylindole (300 nmol in PBS) for labeling
nuclei. Images were taken with a Zeiss LSM 800 confocal microscope (Zeiss, Canada). For testing
fluorescence signaling in ECM, fibrin-based gels were prepared in a glass mold.15 A known
amount of PEA-SiO2 or PEA-BG microparticles (BG composition: 85% SiO 2 -10% CaCl2 -5%
P2 O 5 ), was added to the solution of fibrinogen and 10T1/2 cells. After 2 days of culture, in a Petri
dish, the tissue constructs were cut and transferred to a well of a 24-well plate. The viability of the
cells in the gels was measured using resazurin assay (Sigma-Aldrich). The culture media was
aspirated and after two washing steps with PBS at 37 °C, a solution of resazurin in PBS was added
to the wells, followed by incubation at 37 °C for 5 h. Then, the absorbance was measured at 572
and 600 nm. A blank sample was used for background reading. For staining purposes, the gels
were fixed with 4% paraformaldehyde and immersed in OCT compound (Fisher Scientific,
Canada). Tissue sections of 10 μm were obtained using a Leica cryostat (Leica) and were fixed in
cold acetone and stained for nuclei and F-actin and imaged as described above. To evaluate the
distribution of cells and microparticles in the gels, only cell nuclei were stained, and images were
taken using a Compound Fluorescence ZeissZ1 Microscope (Zeiss, Canada).
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4.3.8. Statistical analysis
Where applicable, statistical data analysis was conducted using one-way ANOVA with Tukey's
post hoc multiple comparison tests (GraphPad Prism). For statistical significance, a p-value of <
0.05 was used.

4.4.

Results

4.4.1. Preparation of organic-inorganic hybrid microparticles
Aqueous sol-gel process in acidic pH and in the presence of polymer was used to prepare the PEAbioglass microparticles. The inorganic component is formed by the hydrolysis and subsequent
polycondensation of the alkoxide precursors. In order to explore if the timing of the PEA addition
had an effect on the microparticle formation under acidic pH, one-stage and two-stage approaches
were used. In the one-stage approach, the PEA, inorganic precursors, and all the solvents were
mixed for hydrolysis and subsequent polycondensation to proceed at d ifferent temperatures. In the
two-stage approach, the inorganic precursors were first allowed to hydrolyze and form the sol at a
pH of ~1.4. The sol was then mixed with the polymer, which increased the pH to ~2.6 and the
polycondensation (gel formation) proceeded at different temperatures. The following observations
were made: (i) in both approaches, microparticles were not formed when the mixture was kept
below 40 °C regardless of time (Figure 4.1A-C), demonstrating that adding the polymer before or
after hydrolysis did not matter; (ii) in the absence of the polymer, the sol-gel product did not form
microparticles regardless of temperature suggesting that the polymer is an important component.
Since microparticles were formed in the presence of the polymer and at a minimum temperature
of 40 °C, the effect of temperature on the morphology of the microparticles was examined. The
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SEM images presented in Figure 4.1D-H showed that the particle size decreased as the temperature
was changed from 40 °C to 50 °C, reaching the lowest at 60 °C (Table 4.2). Above 60 °C, the
microparticles lost their sphericity and appeared to have an elongated and aggregated shape
presumably, due to the softening of the polymer leading to particle-particle sticking and fusion.

Figure 4.1. Effect of temperature and the composition on the morphology of hybrid microparticles .
Hybrid (A) mixed for 2 h at RT (without gelation) (B) mixed for 3 d ays at RT (without gelation)
(C) gelled at RT (D) gelled at 40 °C (E) 50 °C (F) 60 °C (G) 80 °C (H) 100 °C (I) increasing the
organic solvents (J) HCl/TEOS molar ratio of 0.09 (K, L) substitution of HCl with citric acid (M)
omitting ethanol in the initial inorganic sol (N) PEA-(85% SiO 2 -15% P2 O 5 ) hybrid microparticles
(O) microparticles with the organic/inorganic ratio of 3:2 (P) PCL-SiO 2 microparticles.
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The effects of different synthesis parameters (such as the amount of the organic solvent, type of
acid catalyst, the presence of ethanol, the H 2 O/TEOS ratio, and the type of polymer) on the
morphology of the hybrid microparticles were investigated, and the following observations were
made. (i) Increasing the amount of organic solvents to 1.5× of their initial values led to the
aggregation of particles to the point of deterioration of their spherical shape (Figure 4.1I). On the
other hand, decreasing the solvent caused a considerable increase in the viscosity of the polymer
solution, which made mixing difficult. (ii) Similar to the importance of PEA, the presence of HCl
catalyst was equally important for microparticles formation; however, HCl/TEOS molar ratio
between 0.005 and 0.09 was sufficient to avoid phase separation, as shown by the representative
SEM image of the PEA-SiO 2 microparticles with HCl/TEOS of 0.09 (Figure 4.1J). (iii)
Substitution of HCl with citric acid did not influence the morphology and surface topography of
the spherical hybrid microparticles (Figure 4.1K, L). Although organic acids are reported to form
hydrogen bonds with silicate species and affect the surface morphology of bioactive glass
particles,16, 17 this was not observed to be the case in our system. However, some particles from
the citric acid system seemed to have formed from the dissolution and merging of the submicron
particles (Figure 4.1L). A similar observation was made for the sample without ethanol in the
inorganic sol (Figure 4.1M). The re-dissolution of formed particles has also been observed in the
synthesis of mesoporous SBA-15 nanoparticles before aging.13 (iv) Doubling the H 2 O/TEOS ratio
did not cause any morphological change on the final microparticles. However, it should be noted
that PEA, as a water-insoluble polymer, did not precipitate in the presence of water owing to the
water-miscible organic solvents, and this would put a restriction on the maximum amount of water
that can be used. (v) In addition, changing the organic/inorganic (O/I) ratio of the hybrid did not
affect the particle morphology as well (Figure 4.1O). Therefore, particulate morphology is not
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limited to a specific ratio of organic and inorganic components of the hybrid. (vi) Replacing PCL
as the polymer component instead of PEA resulted in microparticles with similar morphology as
PEA-SiO 2 (Figure 4.1P), suggesting that the synthesis procedure can be utilized for other
biodegradable polymers to prepare hybrid microparticles with different organic components.

Table 4.2. Average PEA-SiO 2 particle size prepared under different temperatures. Data are mean
± SD of at least 100 microparticle diameters measured across several SEM images of a one-stage
synthesis approach using ImageJ software.
Gelation Temperature (°C)

Particle size (μm)

40

5.0 ± 0.9

50

4.6 ± 0.9

60

4.4 ± 0.8

Using TEP and CaCl2 as phosphorous and calcium sources, respectively, a series of PEA-bioactive
glass (1:1) with different compositions of the bioactive glass was made (Figure 4.1N and Figure
4.2A-E). There is no need for any modulation of the synthesis parameters for using TEP and CaCl2.
Figure 4.1N shows the fusion of small particles on the surface of larger particles, suggesting
aggregation and fusion as a potential mechanism of particle growth. Keeping the P 2 O 5 content at
5%, the silica content could be reduced to 70% and substituted with CaCl2 (Figure 4.2A, B),
although the particles with 70% SiO 2 were highly aggregated. Reducing the silica content further
destroyed the particulate morphology (Figure 4.2C). Keeping the CaCl2 content to 10%, the silica
content could be reduced up to 55% and substituted with P 2 O5 (Figure 4.2A, D, E). Reducing the
silica content further destroyed the microparticles morphology.
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Figure 4.2. Effect of changing the molar composition of inorganic phase or cargo loading, on the
morphology of hybrid microparticles. (A) PEA-(85% SiO 2 -10% CaCl2 - 5% P2 O5 ) (B) PEA-(70%
SiO2 -25% CaCl2 - 5% P2 O 5 ) (C) PEA-(40% SiO 2 -55% CaCl2 - 5% P2 O 5 ) (D) PEA-(70% SiO 2 -10%
CaCl2 - 20% P2 O5 ) (E) PEA-(55% SiO 2 -10% CaCl2 - 35% P2 O5 ) (F) rhodamine123 single-loaded
microparticles (MP) (G) Nile blue single-loaded MP (H) Nile blue and rhodamine123 dual-loaded
MP (All images have O/I ratio of 1:1).

If the microparticles are prepared using the two-stage synthesis approach, they have the potential
to be loaded with two drugs with similar or different physical properties. The incorporation of
drugs in the microparticles provides the possibility of using these particles as a delivery carrier,
while the loading can be conveniently carried out during the synthesis. Moreover, the
microparticles can be utilized either as a single- or dual-loaded drug delivery system. Here, Nile
blue A was used as a relatively hydrophobic model drug, dispersed in the PEA solution and
rhodamine123 as a relatively hydrophilic compound, dispersed in the inorganic sol to synthesize
single- and dual-loaded PEA-SiO2 hybrid microparticles. Incorporating these model compound s
into the microparticles during the synthesis did not affect the morphology of the microparticles
(Figure 4.2F-H).
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4.4.2. Characterization of hybrid microparticles
Figure 4.3 collectively shows the characterization of hybrid microparticles with an organicinorganic weight ratio of 1:1. The inorganic part was either 100% silica or BG (85% SiO 2 -10%
CaCl2 -5% P2 O5 ). Figure 4.3A and Table 4.3 showed the expected and identified FTIR spectra
peaks of the PEA and PEA-BG hybrid microparticles.
Table 4.3. Assignments of Infrared vibrational modes.
Frequency (cm-1 )

Assigned vibrational mode4

435
695
625-770
792
947
1032
1170
1230-1330
1343
1530
1730, 1650
2850, 2925
3050
3300

Si-O-Si rocking
CH 2 rocking
Amide IV, O=C-N deformation
Si-O-Si bending
Si-OH
Si-O-Si asymmetric stretching
C-O asymmetric stretching
Amide III, N-H in-plane bending and C-N stretching
CH 2 wagging
Amide II, N-H bending
C=O
CH 2 symmetric and asymmetric stretching
Amide B
Amide A, N-H stretching

The XRD spectra of PEA and the PEA-BG hybrid microparticles (Figure 4.3B) demonstrated the
semi-crystalline structure of PEA, that was absent in the hybrid microparticles, showing an
amorphous structure. The reduced crystallinity of the PEA in the microparticles was attributed to
the confined movement of the polymer chains in the amorphous glass network, which led to t he
suppression of its crystallization in the microparticles.5 The SEM and EDX elemental distribution
of PEA-BG microparticles (Figure 4.3C) showed the spherical morphology and uniform
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distribution of the elements in the hybrid microparticles. Furthermore, the hybrid microparticles
have intrinsic fluorescence over a range of wavelengths (Figure 4.3D).
Since the hybrid microparticles are prepared at low pH, the PEA may be susceptible to acid
hydrolysis. In order to evaluate this possibility, the PEA was extracted from dried microparticles
using DMF, and 1 H NMR and molecular weight (MW) changes were measured. Similar chemical
shifts and integrated peak areas were observed before and after microparticles preparation with an
HCl/TEOS ratio of 0.03 (Figure 4.4A), strongly suggesting that the chemical composition of the
PEA remained the same. The appearance of a peak at 3.65 ppm due to unesterified diols, a decrease
of integral of the peak at 4.16 ppm (esterified diol), and change of integral of peak related to sebacic
acid (due to hydrolysis of amide groups) are changes reported to be detected in the 1 H NMR
spectrum of degrading PEAs.18 The percentage of Mw change was calculated using the following
equation:

𝑀𝑊 𝐶ℎ𝑎𝑛𝑔𝑒 (%) =

̅𝑊0 − 𝑀
̅𝑊𝑡
𝑀
× 100
̅𝑊0
𝑀

̅𝑊0 is the initial MW of the PEA and 𝑀
̅𝑊𝑡 is the MW of the extracted PEA. As presented in
Here, 𝑀
Figure 4.4B, all the peaks had a narrow unimodal distribution for all HCl/TEOS molar ratios.
When the HCl/TEOS molar ratio in the feed was below 0.01, the peaks slightly shifted to higher
elution volume with a corresponding MW reduction of ~ 9%. However, above the HCl/TEOS
molar ratio of 0.01, the elution volume shifted further to higher values with a corresponding 59%
MW change when the HCl/TEOS molar ratio was 0.09.
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Figure 4.3. Characterization of fluorescent hybrid microparticles. (A) FTIR spectra and (B) XRD
spectra of PEA and PEA-BG microparticles (C) SEM image and EDX elemental mapping of PEABG microparticles showing their homogeneity (D) Fluorescent images of PEA-SiO 2 microparticles
showing their intrinsic fluorescence.
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Since HCl/TEOS molar ratios between 0.005-0.09 did not change the morphology of
microparticles, the lowest amount of HCl can be used to minimize PEA degradation at low pH.
Comparison of number average molecular weight of the PEA before and after microparticle
preparation showed that with an acid molar ratio of 0.03, on average, only 0.8 bonds per molecule
were cleaved (number of chain bonds split per molecular chain =

̅𝑛0
𝑀
̅𝑛𝑡
𝑀

− 1).19 For the HCl/TEOS

ratio of 0.01, only 0.25 bonds per chain were cleaved.

Figure 4.4. PEA degradation extent in the course of PEA-SiO 2 microparticles synthesis. (A) 1H
NMR spectra of PEA before and after microparticles synthesis (HCl/TEOS ratio = 0.03) (B) PEA
molecular weight distribution after microparticles synthesis with the indicated HCl/TEOS molar
ratios.
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4.4.3. In vitro bioactivity and degradation evaluation
Deposition of hydroxyapatite (HA) on the surface of bone biomaterial following incubation in SBF
is a standard test for evaluating in vitro bioactivity and in vivo bonding to the bone.20 After
incubation in SBF for 1 and 3 days, there was no HA deposition on the surface of PEA films
(Figure 4.5A). Subsequently, the elemental mapping of PEA film only showed signals for carbon
and oxygen. On the contrary, the smooth surface of hybrid microparticles was covered with HA
(Figure 4.5B, C). Higher magnification images revealed the needle-like crystals of HA. Compared
with the smooth surface of microparticles which showed a homogenous distribution of all elements
in EDX elemental mapping, in regions with deposited HA crystals, the signals of C and Si were
attenuated while the signals of Ca and P were amplified. Figure 4.5D shows the XRD spectra of
hybrid microparticles after SBF incubation. In comparison to the amorphous nature of PEA-BG
(Figure 4.3B), the peaks at 2θ = 31.6 and 45.4° corresponding to (211) and (203) diffraction planes
of HA were detected.21 The XRD spectrum of samples incubated for 3 days showed prominent
and sharp peaks, suggesting the evolution of HA over time. Figure 4.5E shows the degradation
profiles of the PEA and PEA-BG hybrids. As can be seen, the PEA has the lowest degradation rate
with 93.2% mass remaining after 28 days of incubation in PBS, followed by PEA-silica hybrid
with 64.4% and PEA-BG hybrid with 56.1% remaining mass after 28 days. Interestingly, the same
PEA had degraded by about 21% when it was in the form of an electrospun mat 22 compared to the
7% in this study when it was in the form of a disk. This difference is attributed to the lower surface
area of the disk compared with the electrospun fiber mat. The degradation rate of the present PEA BG microparticles is consistent with other hybrid materials having similar compositions.23
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Figure 4.5. In vitro bioactivity and degradation. SEM images of the surface of (A) PEA films and
(B) PEA-BG microparticles after 0-, 1- and 3-day incubation in SBF and EDX elemental mappings
after 3-day incubation in SBF (C) Higher magnification SEM and EDX of regions of panel B
images shown by black squares (D) XRD spectra of microparticles after 1- and 3-day incubation
in SBF (E) Degradation of PEA, PEA-silica and PEA-BG disks after incubation in PBS at 37 °C
(n = 3). Note that the fits are visual aids and are not intended to suggest degradation kinetic
parameters.
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4.4.4. In vitro model drugs release profiles of the hybrid microparticles
To investigate the potential use of the microparticles for delivering therapeutic agents,
microparticles were loaded with model drugs. Initially, the microparticles were loaded with a
single model drug of either Nile blue A or rhodamine 123 and the release profiles of each
compound were investigated. Figure 4.6A demonstrates the release profiles of Nile blue A and
rhodamine 123 from single drug loaded microparticles (i.e., single-loaded). A sustained release of
Nile blue was observed for 13 days whereas rhodamine123 showed a burst release, with 48%
cumulative release in the first 24 h and plateaued after 54% cumulative release. Following this,
both model drugs were loaded into the microparticles (i.e. dual-loaded microparticles). As shown
in Figure 4.6B, the co-presence of the model drugs did not affect both the release profile and the
cumulative amounts for each compound, suggesting the absence of interactions between the two
compounds. A comparison of the model drug release between the single-loaded and dual-loaded
microparticles further demonstrated that the presence of Nile blue did not considerably impact the
release of rhodamine123 and vice versa (Figure 4.6C, D). It is noteworthy that physicochemical
interactions between the microparticles and drugs as well as between d rugs may affect release
profiles. Such interactions are dependent on the chemical nature of the loaded drugs and must be
studied for each target drug or combination of drugs.24 In view of this, the present hybrid
microparticles are good candidates for delivering one or two therapeutic agents.
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Figure 4.6. Release profiles of Nile blue A (NB) and Rhodamine123 (Rh123) from PEA-SiO2
hybrid microparticles in PBS + 30%EtOH. (A) NB and Rh123 release profiles from single-loaded
MPs (B) NB and Rh123 release profiles from dual-loaded MPs (C) comparison of NB release
profiles from single- and dual-loaded MPs (D) comparison of Rh123 release profiles from singleand dual-loaded MPs. Note that the error bars are too small to be visible on the plots.

4.4.5. Osteogenic gene expression of 10T1/2 cells cultured with microparticles
Runx2 is one of the known early osteogenic differentiation markers and was significantly
upregulated in the presence of PEA-BG microparticles after 8 h of culture (Figure 4.7A). Two
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other osteogenic differentiation markers, namely, alkaline phosphatase (Alpl) and osteopontin
(Spp1) were also significantly upregulated in the presence of the microparticles (Figure 4.7B, C).
The interesting observation is that without osteogenic media, the presence of the microparticles
alone was sufficient to induce bone-specific differentiation of 10T1/2 cells.

Figure 4.7. 10T1/2 cells osteogenic gene expression. (A) Runx2 (B) Alpl and (C) Spp1 mRNA
expression of 10T1/2 cells cultured with osteogenic media and normal media containing 5 mg/mL
PEA-BG microparticles (n = 4). Results were normalized to GAPDH expression. One-way
ANOVA and Tukey's multiple comparison tests were used for statistical analysis. Different letters
indicate the significance at p < 0.05, while similar letters indicate no significance (p > 0.05).
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4.4.6. 10T1/2 cells attachment and spreading on PEA-BG hybrid and
distribution of cells in fibrin gels containing hybrid microparticles
Figure 4.8A1 shows the intrinsic fluorescence of the PEA-BG microparticles (compressed as a
disk), consistent with the intrinsic fluorescence observed on a single particle or clusters of particles
earlier (Figure 4.3D). When 10T1/2 cells were seeded on the disks, cells were observed spreading
on the surface, making both cell-material and cell-cell contacts as shown by the nuclei and F-actin
staining (Figure 4.8A2-A4).
The fluorescence property of the PEA-SiO 2 microparticles was further used to evaluate their
distribution in fibrin gels. Figure 4.8B1 shows the intrinsic fluorescence of microparticles
embedded in fibrin gel, demonstrating the detection of the fluorescence signal. Furthermore, when
cells were embedded in the microparticle/fibrin gel system, nuclei staining demonstrated the
uniform distribution of both cells and microparticles in the cross-section of the gel (Figure 4.8B2,
B3). Measuring the absorbance of reduced resazurin from tissue constructs containing different
concentrations of microparticles was used to assess the viability of cells. Figure 4.8C shows the
absorbance of the reduced resazurin after 4 and 7 days of culture in the three-dimensional fibrin
gel/ microparticle system to simulate the bone ECM. Cells in the control gel (no microparticles)
showed higher level of reduced resazurin absorbance compared to the gels with microparticles.
Since uniformly distributed cells have been observed within the fibrin gel/microparticle crosssection (Figure 4.8B2, B3), the observed lower absorbance is not an indication of lower cell
variability, but likely attributed to diffusional barriers. The diffusion of the dye (resazurin and its
reduced form) into and out of the gel is limited and is dependent on the size of the cell/gel system.
Because the fibrin gel shrunk considerably in the absence of microparticles, it will have lower
diffusional path compared with the gels in the presence of microparticles thus the absorbance is
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mostly influenced by the cells on the surface of the tissues rather than those embedded in them.25
To test this possibility, cells were seeded on the surface of gels instead of embedding them and the
presence of the microparticles had no effect on the absorbance (data not shown). Overall, the
metabolic activity of these tissues was stable over time. Confocal images of sections of each tissue
(stained for cell nuclei and F-actin) are presented in Figure 4.8D-F. Cells were distributed
uniformly in all cases, and there was no difference between cells embedded in the fibrin gels
without microparticles (0 mg/mL microparticles) and cells in fibrin gels containing 20 or 80
mg/mL of microparticles.

4.5.

Discussion

Despite the widespread utilization of the Stöber process for silica particle formation,26, 27 acidic
conditions may also achieve a similar outcome. To date, the inclusion of only water-soluble
polymers (poly(sodium styrenesulfonate),28 poly(acrylic acid),29 PEG,11 chitosan,10 and Pluronic
polymers such as F12730 and P12331 ) have been reported for low pH preparation of particles by
the sol-gel process. Because these polymers were used as templating and phase separation agents,
they had to be removed by dissolution or calcination, leaving only the inorganic particle. The use
of only water-soluble polymers in the sol-gel system precludes several important biodegradable
polymers that are not water-soluble. In the current study, PEA-Silica and PEA-BG hybrid
microparticles have been prepared by introducing water-insoluble PEA to the inorganic sol under
acidic conditions where the PEA was homogeneously dispersed and remained as an integral part
of the particles after the synthesis. There are three key factors in the synthesis process introduced
here: (i) the presence of a biodegradable and water-insoluble polymer, (ii) acidic pH, and (ii)
gelation at the temperature of 40-60 °C.
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Figure 4.8. 10T1/2 cell attachment and distribution on hybrid microparticles and fibrin gels. (A1)
intrinsic fluorescence of the microparticles after compression molding to form a disk (A2-4)
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Confocal fluorescent images of cells on the surface of PEA-BG hybrid disks after 24 h culture
(scale bar = 20μm) (B1-3) Fluorescent images of fibrin gel containing 100 mg/mL of PEA-SiO2
microparticles showing the distribution of microparticles and cells in the cross-section of the gel
(C) Resazurin cell viability assay of fibrin gel/microparticles/cell constructs containing 0, 20, and
80 mg/mL of PEA-BG microparticles, cultured for 4 and 7 days (n = 3), Confocal fluorescent
images of 3D constructs containing (D) 0 mg/mL (E) 20 mg/mL and (F) 80 mg/mL microparticles,
after 7 days of culture. In all fluorescent images, green = intrinsic fluorescence of microparticles,
blue = nuclei, red = F-actin.

Contrary to the Stöber process, the silica alone did not form any particulate morphology under
acidic reaction conditions; therefore, the inclusion of PEA into the sol-gel reaction is essential for
forming microparticles. However, this process is not limited to PEA since PCL have been also
used to prepare hybrid microparticles. Therefore, the synthesis method is versatile and can be
potentially used to prepare hybrid microparticles with different organic components. Similarly, the
acid catalyst for the sol-gel reaction is not limited to HCl only, and hybrid microparticles using
citric acid were also prepared. In the current study, the temperature of gelation affected the
morphology. At RT, gelation took several days, and only ill-defined irregular shapes were formed
(Figure 4.1C). Increasing the temperature to 40-60 °C resulted in faster gelation and well-defined
microparticles. At higher temperatures of 80 °C and 100 °C, the gelation was unfavorably faster
than 60 °C, thus, irregularly shaped and highly aggregated particles formed attributed to the
softening of the PEA. The Stöber process (changing the system to alkaline pH of > 8 by replacing
HCl with NaOH) did not form microparticles (data not shown) and resulted in PEA precipitation
and likely a rapid degradation. Since degradation is faster in alkaline conditions than acidic
conditions for common biodegradable polymers,32, 33 the stability of the PEA under acidic pH in
our study was a critical design goal as shown in Figure 4.4.
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Emulsion,34 phase separation,35 and nucleation and growth36 are three mechanisms suggested for
the formation of silica and silica-polymer particles under acidic conditions. The hybrid
microparticle formation in the current system cannot be explained by emulsion or phase separation
mechanisms, as the emulsion technique needs the system to be relatively dilute with regard to one
phase. However, in the current system, creating a dilute solution resulted in the deterioration of
particulate morphology or even phase separation. In addition, the sol-gel process occurred in a
single homogeneous system without separation thus, the microparticles are unlikely to have
formed due to phase separation.28, 29 In view of this, it is believed that nucleation and growth is the
primary mechanism of hybrid microparticle formation. Nucleation involves the formation of
oligomeric silicate species through hydrolysis of TEOS, followed by growth through either
aggregation or monomer addition or a combination of the two.37, 38 However, further studies are
required to elucidate this mechanism and to gain an understanding of the role of the polymer in
particle nucleation and growth.
Biomaterials with intrinsic fluorescence/luminescence circumvent the common drawbacks of
conventional fluorescent moieties, such as the complexity of conjugation or incorporation,
concerns about the toxicity of quantum dots, and low photostability of fluorescent dyes. Although
luminescent polymers are, in general, highly conjugated systems formed by π-aromatic building
blocks, non-conjugated fluorescent polymers are also known.39, 40 Aggregation and clustering of
carbonyl groups and interactions between carbonyl and phenyl groups are reported to be the
luminescence mechanisms in maleic anhydride polymers, poly(amido-amine)s41 and poly(Nisopropylacrylamide).42 In our hybrid PEA-SiO 2 microparticles (Figure 4.3D), the observed
fluorescence may have been a combination of carbonyl and phenyl group interactions since Lphenylalanine is an aromatic amino acid known for its fluorescence properties 43 despite its low
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quantum yield and extinction coefficient. What is interesting about these PEA-silica microparticles
is that their emission is tunable by changing the excitation wavelengths ranging from 300 to 565
nm for potential multiplex imaging. Such PEA-derived bioactive glass fluorescent hybrids could
function as implants to repair bone and as imaging probes to non-invasively investigate host
integration. While mesoporous fluorescent silica nanoparticles doped with perylenediimide dye44
and fluorescently conjugated oligomer with embedded silica nanoparticles have been reported ,45
our study is the first to prepare hybrid microparticles without dye modification or the use of
conventional conjugated polymers. For intrinsic luminescent and biodegradable biomaterials,
derivatives of poly(citrate) and polylactones46-48 appeared to be the only materials studied in the
past and, our study extends the library of emerging biodegradable luminescent materials.
The bioactivity of inorganic bioglass-based materials is one of the main reasons for using them for
hard tissue regeneration. Data collectively presented in Figure 4.5 showed the deposition of a Caand P-rich layer on the surface of microparticles in the form of HA-like crystals, while PEA alone
did not show any bioactivity. The use of a two-stage synthetic approach enabled us to load two
different compounds in the microparticles. The co-delivery of two model drugs from mesoporous
silica nanoparticles has been an active research over the past few years.49, 50 Here, a combination
of inorganic and organic phases was used for dual loading to simultaneously harness the properties
of individual phases, i.e., bioactivity and intrinsic fluorescence. Compared to other multi-step dual
drug-loaded silica particulate systems (e.g., mesoporous silica nanoparticles with polymer layer at
the surface),51, 52 our approach allows loading of two model drugs during the microparticle
formation and reduces the complexity of post-synthesis drug loading.
The potential of hybrid microparticles to induce osteogenic differentiation was demonstrated
through the upregulation of osteogenic genes. An osteogenic medium having three supplements,
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namely β-glycerophosphate, ascorbic acid, and dexamethasone, is known to induce osteogenic
differentiation. In contrast to many studies which evaluated the effect of biomaterials in the
presence of osteogenic media supplements, PEA-BG hybrid microparticles were able to induce
osteogenic differentiation without osteogenic media supplements. Our results are consistent with
microcarriers based on doped phosphate glasses53, 54 and also silica nanoparticles doped with
calcium and phosphate ions55 and clearly show the potential of hybrid microparticles as a standalone system for the promotion of osteogenesis. The cytocompatibility of the hybrid microparticles
and the possibility of their use in a 3D structure were tested by fabrication of tissue constructs
composed of fibrin gel, 10T1/2 cells, and hybrid microparticles. Although 10T1/2 embedded in
fibrin gels have been recently reported for Notch signaling and ectopic calcification in engineered
vascular tissues,15,

25

it was chosen here for their osteogenic differentiation potential.56 The

metabolic activity of cells measured using reduction of resazurin was stable for seven days,
irrespective of microparticle concentration (20 or 80 mg/mL) in the gel constructs, which were
considerably higher than typical concentrations used for incorporation of particles in hydrogel
systems or evaluation of cytotoxicity of the particles in cell studies.57-60 The cells and
microparticles were also distributed uniformly over the cross-section of the tissue construct, as
evidenced by fluorescent images (Figure 4.8).

4.6.

Conclusion

In this study, fluorescent homogenous PEA-SiO 2 and PEA-Bioactive glass hybrid microparticles
have been synthesized via a sol-gel process under acidic conditions and a temperature of 60 °C.
The effects of different synthetic parameters on the morphology of hybrid microparticles were
investigated and discussed. Nucleation and growth was suggested as a potential mechanism for the
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formation of these hybrid microparticles. Deposition of hydroxyapatite-like crystals on the surface
of microparticles after 1-day incubation in SBF showed their bioactivity. Hybrid microparticles
with PEA as the organic component were intrinsically fluorescent, which can be utilized for in
vitro or in vivo imaging purposes. Furthermore, the microparticles were loaded with two model
drugs during the synthesis process. The release profiles of model drugs were independent of each
other and both burst and sustained release profiles have been obtained. A single dose of the hybrid
microparticles induced osteogenic differentiation of 10T1/2 cells without osteogenic media
supplements. These hybrid microparticles can be incorporated into the hydrogels to fabricate 3D
scaffolds, as shown here using 10T1/2 cells and fibrin gels. The microparticles can be loaded with
different factors, and through delivering both the loaded compound(s) and stimulatory ions
(released from the inorganic phase), the microenvironment of the cells can be modulated. Taken
together, these hybrid microparticles can be envisioned as a potential platform for bone
regeneration and therapy.
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Chapter 5
5. Bioactive hybrid microparticles as a stand-alone osteogenic
differentiation inducer*
Overview: This study describes the use of poly(ester amide)-bioactive glass hybrid microparticles
as a osteogenic differentiation inducer. Multipotent mouse mesenchymal progenitor cell line
(C3H10T1/2) was cultured with pristine or dexamethasone-loaded hybrid microparticles and the
osteogenic differentiation in the absence of any osteogenic media supplements was evaluated by
both gene and protein expression as well as mineralization.

Scheme 5.1. Graphical abstract of Chapter 5

*This chapter has been submitted for publication. (Aslankoohi, N.; Lin, S.; Mequanint, K., Bioactive hybrid
microparticles as a stand-alone osteogenic differentiation inducer. Revised manuscript under
consideration).

5.1.

Abstract

Osteogenic differentiation of stem cells is one of the essential steps in bone regeneration. While
supplementing exogenous factors through differentiation media is the established method to
differentiate stem cells into osteoblasts in the presence of biomaterials, having biomaterials that
can act as a stand-alone system and promote bone regeneration is preferred for clinical translation.
In this work, organic-inorganic hybrid microparticles synthesized from an intrinsically fluorescent
poly(ester amide) and tertiary bioactive glass (PEA-BG) have been introduced as a stand-alone
osteogenic differentiation inducer. The hybrid microparticles were loaded with one or two
compound(s) during their synthesis. Here, dexamethasone was loaded in the microparticles.
Hybrid microparticles supported cell adhesion and proliferation of C3H10T1/2 cells. Both pristine
and dexamethasone-loaded PEA-BG microparticles were able to induce osteogenic differentiation
of cells in the absence of any media supplement, to a level even higher than standard osteogenic
media, as evidenced by the expression of osteogenic markers on gene and protein levels, and
matrix mineralization. Taken together, the PEA-BG hybrid microparticles have the potential to be
used as a stand-alone system for bone regeneration.

Keywords: Organic-inorganic hybrid microparticles, sol-gel process, poly(ester amide)s,
bioactive glass, dexamethasone delivery, osteogenic differentiation
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5.2.

Introduction

Attempts made so far in bone tissue engineering relied on either the delivery of stem cells through
implantation of cellular scaffolds or hydrogels or recruitment of endogenous stem cells after
implantation of an acellular scaffold. In both scenarios, differentiation of implanted exogenous or
recruited endogenous stem cells to osteogenic lineage is essential for bone repair and regeneration.
In vitro studies to evaluate the differentiation of stem cells in the presence of biomaterials are
mostly conducted using osteogenic media, which is a cocktail of growth medium and three
mediators, namely ascorbic acid, dexamethasone, and β-glycerophosphate. However, these
mediators are absent in vivo1 and hence, these in vitro experimental conditions do not predict the
actual in vivo fate of the biomaterials and cells. Moreover, even if the implantation of predifferentiated cellular scaffolds is considered, the use of these osteogenic mediators may obscure
the real effect of biomaterials.2 To close this gap, different strategies for induction of differentiation
by biomaterials in the absence of media supplements, such as the use of growth factors (e.g., bone
morphogenic proteins) or the synthetic peptide counterparts, 3 geometrical and topographical cues
affecting the cell fate4 and their combination with growth factors,5 and the use of co-culture to
mimic the cellular niche of tissue,1 have been investigated.
Bioactive glasses (BG) have long been studied for their osteoconductive potential stemming from
the release of stimulatory ions.2 The sol-gel chemistry provides the possibility of doping the
bioactive glasses with different ions to provide cues for the cells deliberately. The combinatory
delivery of stimulatory ions of bioactive glasses and osteogenic factor(s) have also been studied to
promote bone regeneration.6-8 In terms of morphology, particulate morphology specifically
provides flexibility for filling bone defects of different shapes and sizes, offers a higher surface
area for cell-material interaction, and can be introduced in injectable formulations. Recent studies
117

have shown the ability of BG nanoparticles to direct cells towards osteogenic differentiation in the
absence of media supplements through the release of different ions such as calcium, phosphate,
and strontium ions.9,

10

Tavares et al. also showed that a single dose of mesoporous silica

nanoparticles loaded with dexamethasone and functionalized with calcium and phosphate ions
could induce osteogenic differentiation in human bone marrow mesenchymal stem cells. 8 While
the inorganic glasses can be exploited for osteoconductivity, the inclusion of an organic phase in
the form of a hybrid biomaterial can introduce additional functionality. However, sol-gel reaction
conditions frequently used to prepare bioactive glass nano- and micro-particles either utilize highly
basic conditions and/or need a post-synthesis calcination step to remove surfactants used in the
synthesis, which neither is compatible with biodegradable polymers. In Chapter 4, a versatile
synthesis approach for the preparation of bioactive and biodegradable polymer-bioactive glass
hybrid microparticles with the possibility of dual-drug loading during synthesis was reported.11 In
this Chapter, the potential of these polymer-BG hybrid microparticles, having intrinsically
fluorescent poly(ester amide) (PEA) as their polymer component, in their pristine form or loaded
with dexamethasone, a known osteogenesis inducing factor, to differentiate murine mesenchymal
progenitor cells (C3H10T1/2 cells) into osteogenic lineage as a stand -alone system is investigated
(Scheme 5.2).
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Scheme 5.2. Schematic illustration of experimental design. Pristine or dexamethasone-loaded
PEA-BG hybrid microparticles are added to the media in a single dose to induce osteogenic
differentiation.

5.3.

Materials and Methods

5.3.1. Materials
Tetraethyl orthosilicate (TEOS, 98%), triethyl phosphate (TEP, 99.8%), dexamethasone, Alizarin
Red S, and L-ascorbic acid were purchased from Sigma-Aldrich (Milwaukee, WI, USA).
Dimethylformamide (DMF) was purchased from Caledon Laboratory Chemicals (Georgetown,
ON, Canada). Methyl ethyl ketone (MEK) and calcium chloride dihydrate were purchased from
Fisher Scientific. Poly(ester amide) (PEA), specifically 8-Phe-4, was synthesized by interfacial
polymerization according to the previous publication,12 using sebacoyl chloride, L-phenylalanine,
and butanediol.
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5.3.2. Synthesis of organic-inorganic hybrid microparticles
Sol-gel process in the presence of organic phase was conducted to obtain class I hybrid
microparticles (MPs) according to our previous publication. 11 Briefly, a known amount of PEA
was dissolved in DMF and MEK. The ratio of organic to inorganic components was kept at 50
wt%, and the inorganic component was tertiary bioactive glass with either the molar composition
of 70% SiO 2 -10% CaCl2 -20% P2 O 5 [Hybrid (70Si)] or 85 %SiO 2 -10% CaCl2 -5% P2 O5 [Hybrid
(85Si)]. An inorganic sol was prepared separately at room temperature (RT) and then was added
to the polymer solution. After complete mixing, the solution was transferred to 60°C until gelation,
followed by drying under vacuum at 60°C. For dexamethasone-loaded microparticles,
dexamethasone was added to the polymer solution prior to mixing with the inorganic sol.

5.3.3. Characterization of hybrid microparticles
The morphology of the hybrid was visualized using scanning electron microscopy (LEO 1540XB
SEM, Hitachi, Japan). Samples were mounted on a sample holder using carbon tape and then
sputter-coated with gold/palladium (K550X sputter coater, Emitech Ltd., UK) prior to
visualization. To measure the in vitro release profile of dexamethasone, hybrid microparticles with
0.6 wt% dexamethasone were immersed in PBS at 37°C with shaking at 120 rpm. At each defined
time point, aliquots were removed and replaced with fresh pre-warmed PBS. Samples were
removed and analyzed with UV-VIS spectrophotometer at 242 nm. The experiment was conducted
in triplicate.

5.3.4. In vitro cell culture with hybrid microparticles
Embryonic multipotent mesenchymal-like progenitor cell line (C3H10T1/2 cells) (ATCC) were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Thermo Fisher) containing 5% Fetal
120

Bovine Serum (FBS) (Thermo Fisher) and 1% penicillin/streptomycin. Cells were seeded in a 24well plate with a seeding density of 5×104 per well. After reaching confluency, the cell culture
media is aspirated and replaced with either media containing PEA-BG microparticles [Hybrid
(70Si)], disinfected by exposure to UV light for 10 minutes, or osteogenic media (day 0),
depending on the experimental design. For all experiments evaluating the differentiation of cells,
a concentration of 5 mg/mL microparticles was used. Cells cultured with DMEM media were used
as a control. Osteogenic media contained 10-7 M dexamethasone, 50 μg/mL ascorbic acid, and 3
mM Nax H3-x PO4 . The medium was changed every 3 days. At least three replicates were used for
each experiment.
For staining purposes, a glass slide was inserted at the bottom of wells prior to cell seeding. After
a pre-determined time, cells were fixed using 4% paraformaldehyde (PFA) (EMD Chemicals Inc.
Gibbstown, NJ) and stained with Alexa-Fluor 568 conjugated phalloidin (1:100; Thermo Fisher)
to visualize F-actin and counterstained with 4´,6-diamidino-2-phenylindole (DAPI, 300 nM in
PBS, Thermo Fisher, Canada) for labeling nuclei. Images were taken with a Zeiss LSM 800
confocal microscope (Zeiss, Canada).

5.3.5. 10T1/2 cells adhesion to hybrid biomaterial
To investigate the adhesion of cells to the hybrid material, a layer of hybrid was coated on glass
slides by dipping them three times in hybrid solution followed by drying at 60°C under vacuum.
The samples were disinfected by immersion in 70% ethanol for 30 min followed by two washes
with HBSS and subsequently seeded with 10T1/2 cells (15000 cells/cm2 ). Cells cultured on glass
slides were used as a control. To visualize focal adhesions of the cells after a pre-determined time,
cells were fixed using 4% PFA and then were permeabilized for 10 min with 0.1% Triton X-100
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in PBS and rinsed three times with PBS. Cells were then blocked with 1% BSA in PBS for 30 min
at ambient temperature, followed by overnight incubation (at 4°C) with anti-vinculin antibody
(1:50; MAB3574, clone VIIF9, EMD Millipore). The primary antibody binding was detected using
Alexa Fluor 594 goat anti-mouse IgG as a secondary antibody (1:300; Thermo Fisher, Canada).
The cells were counterstained with DAPI for labeling nuclei. To visualize cytoskeleton, cells were
stained with Alexa-Fluor 568 conjugated phalloidin (1:100) and counterstained with DAPI.
Images of single cells with labeled F-actin were used to determine cell area using ImageJ software.
Images of cells with labeled vinculin were used to determine the number of focal adhesions per
cell using the particles analysis feature of ImageJ software with area threshold of 0.1 - 0.5 μm2 .13
The area threshold was selected to include only vinculin-labeled areas associated to focal
adhesions at the periphery of the cells and exclude perinuclear vinculin not involved in focal
adhesion points.

5.3.6. Metabolic activity and proliferation of cells
The metabolic activity of the cells was measured using MTT assay (Sigma-Aldrich), following the
manufacturer’s protocol, and the absorbance was measured using an Asys UVM 340 plate reader
at a wavelength of 570 nm with reference to 680 nm. To measure cell proliferation, CyQuant cell
proliferation assay kit (Invitrogen, Canada) was used according to the manufacturer’s protocol,
and the fluorescence intensity was measured with a Tecan Infinite M1000 Pro fluorescence plate
reader.

5.3.7. Osteogenic gene expression of 10T1/2 cells
For osteogenic gene expression experiments, after a pre-determined time, total RNA was extracted
using Trizol (Thermo Fisher) following the manufacturer’s protocol. Complementary DNA
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(cDNA) template was prepared by using 1 μg of total RNA primed with random primers according
to Promega™ Random Hexamers protocol (Thermo Fisher). qPCR was carried out in 10 μL of
reaction volumes, using a CFX96™ Real-Time System (C1000 Touch Thermal Cycler; Bio-Rad,
Canada) and then measured with iQ™ SYBR ® Green Supermix (Bio-Rad) according to the
recommended protocol by the manufacturer. The sequences of primers were designed using
Primer3Web and are presented in Table 5.1. The results were analyzed with the comparative
threshold cycle method and normalized with GAPDH as an endogenous reference and reported as
relative values (ΔΔ CT) to the negative control.

Table 5.1. Primers for mouse-specific mRNA amplification.
Gene
Alpl
Spp1
Runx2
Bglap
IBSP
Sp7
GAPDH

Forward primer (5´→ 3´)
CCTTCACGGCCATCCTATATG
ATCTCACCATTCGGATGAGTCT
CACTGGGTCACACGTATGATT
GGCCCAGACCTAGCAGACAC
GAGCCAGGACTGCCGAAAGGAA
GCCAGTAATCTTCAAGCCAGA
GGTGGTCTCCTCTGACTTCAACA

Reverse primer (5´→ 3´)
CTGGTAGTTGTTGTGAGCGTA
TGTAGGGACGATTGGAGTGAAA
AGGGAAGGGTTGGTTAGTACA
TTGCCCTCCTGCTTGGACAT
CCGTTGTCTCCTCCGCTGCTGC
CCATAGTGAGCTTCTTCCTGG
GTTGCTGTAGCCAAATTCGTTGT

Alp1 - Alkaline phosphatase; Spp1 - Osteopontin; Runx2 - Runt-related transcription factor 2;
Bglap - Bone gamma carboxyglutamate protein; IBSP - Bone sialoprotein; Sp7 - Osterix.

5.3.8. Western blot analysis
Western blotting was performed to evaluate levels of osteogenic biomarker proteins. Briefly,
10T1/2 cells were lysed in buffer containing 150 mM NaCl, 10 mM Tris-HCl (pH 7.4), 1 mM
EDTA, 0.5% Nonidet P-40, and 1% Triton X-100 and supplemented with protease inhibitor
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(Roche Applied Science, Indianapolis, IN). Protein concentrations were determined by Quick
Start TM Bradford Protein Assay (Bio-Rad, Mississauga, ON), and 20-200 μg of total protein lysate
was resolved on 12% SDS-PAGE and subsequently transferred to nitrocellulose membrane. The
proteins of interest were immunoblotted using the following primary antibodies: anti-Osteopontin
(rabbit, 1:2000; Abcam, ab8448) and anti-Osteocalcin (rabbit, 1:250; Abcam, ab133612). Primary
antibody labeling was detected using HRP-conjugated goat anti-rabbit secondary antibody and the
ECL detection system.

5.3.9. Evaluation of mineralization
To assess the mineralization of cultures, cells were fixed with 70% ethanol followed by washing
with PBS and water and incubation with a solution of 40 mM alizarin red S (pH = 4.2). After 30
minutes incubation at RT in the dark, samples were washed three times with water, 15 minutes
each time, under gentle shaking. The stained samples were then visualized by an optical
microscope. To quantify the amount of alizarin red, a protocol reported by Gregory et al. was
followed.14

5.3.10. Evaluation of mechanical properties
To evaluate the mechanical properties of the hybrid material, cylindrical specimens (6 mm
diameter and 9 mm height) were prepared from hybrid microparticles and PEA using compression
molding in a custom-made stainless-steel mold (1 MPa, 100°C, 1 h). Instron Universal Mechanical
testing machine was used to conduct a uniaxial compression test with a 5 kN load cell, 10 N preloading, and a crosshead speed of 1 mm/min (n = 5 for hybrids, and n = 3 for PEA). The slope of
the linear portion of the stress-strain curve was reported as compressive modulus. The toughness
was determined as the area under the stress-strain curve up to the point of 30% strain.
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5.3.11. Statistical analysis
Data were presented as means ± standard deviations (SD). Statistical significance was calculated
using one-way ANOVA with Tukey’s post hoc multiple comparison tests. For statistical
significance, a p-value of < 0.05 was used.

5.4.

Results and discussion

5.4.1. Synthesis and characterization of dexamethasone-loaded organicinorganic hybrid microparticles
Figure 5.1 shows pristine and dexamethasone-loaded PEA-BG hybrid microparticles having a
spherical morphology with a smooth surface topography (Figure 5.1A, B). Drug loading during
the synthesis reduces the overall complexity of the loading process, especially if the loading of
two compounds is intended. Here dexamethasone was loaded in the microparticles during their
synthesis and showed a burst release of 69 % followed by a continuous release for more than 20
days (Figure 5.1C). Similar release kinetics were reported previously for dexamethasone-loaded
carriers such as mesoporous silica nanoparticles,8, 15 and titanium nanotubes.16 Functionalization
of PEA to conjugate bioactive molecules has been previously reported 17 and may be utilized here
to gain more control on the release rate of the microparticles.
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Figure 5.1. Morphology of (A) Pristine and (B) Dexamethasone-loaded PEA-BG hybrid
microparticles (C) In vitro release profile of dexamethasone-loaded microparticles.

5.4.2. 10T1/2 cells morphology, focal adhesion formation, viability, a nd
proliferation in culture with hybrid microparticles
The hybrid microparticles are intrinsically fluorescent due to having PEA as their organic phase. 11
This intrinsic fluorescence is used to visualize microparticles and cells around them after 4 and 7
days in culture (Figure 5.2A). Cells have an intact cytoskeleton and spread on the glass slide and
around the microparticles. Cell adhesion and spreading, i.e. cell shape, can regulate the
differentiation lineage commitment. It has been shown that spread hMSCs committed to
osteogenesis while non-spread and round cells underwent adipogenesis.18 Interestingly, direct
manipulation of RhoA signaling controlled the differentiation fate of MSCs, irrespective of the
differentiation media.18 Therefore, evaluating the cell morphology in contact with biomaterials is
essential in differentiation studies. In order to better visualize the adhesion of cells to the hybrid
solely, cells were cultured on a film of hybrid material. Figure 5.2B-E shows the spreading and
adhesion of the cells on the hybrid material compared to the glass slide. After 6 hours cells have
completely spread on glass slides with organized cytoskeleton. After 24 h, the cell area on glass
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slides increased slightly as well. In comparison, cells on the hybrid after 6 h are more rounded,
however, after 24 hours, cells are well-spread with organized cytoskeleton and a cell area
comparable to the glass slide (Figure 5.2B, D). Vinculin is one of the key proteins regulating focal
adhesion formation and cell adhesion. In the inactive state, vinculin is located in the cytoplasm;
upon recruitment for focal adhesion formation, its conformation changes, facilitating interaction
with several proteins, including actin cytoskeleton.19 The hybrid material supported the attachment
of cells and formation of distinct focal adhesions at the periphery of the cells. There was no
significant difference between the number of focal adhesions per cell at each time point between
the glass slide and the hybrid. The number of focal adhesions increased for both substrates between
6 and 24 hours (Figure 5.2C, E).
The effect of hybrid microparticles on the metabolic activity of the cells was determined by the
MTT assay. The metabolic activities of cultures after 1 day were normalized to tissue culture plate
(TCP) as a control to determine the dose response. While the presence of microparticles caused a
significant decrease in metabolic activity of the cells comparable to TCP after 1 day, the metabolic
activity of cells was not changed significantly between concentrations of 2, 5, and 10 mg/mL
(Figure 5.3A). For cultures containing 20 mg/mL hybrid microparticles, the normalized metabolic
activity was 71.7%. This shows that the half-maximal inhibitory concentration (IC 50 ) of hybrid
microparticles is above 20 mg/mL, which is considerably higher than similar bioactive submicron
particles such as silica particles (365.1 ± 79.5 nm, IC50 = 34.8 μg/mL)20 , and (760 nm, IC50 > 2
mg/mL)21 , and similar bioactive nanoparticles such as silica nanoparticles (100 nm, IC50 = 35.9
μg/mL)22 , magnetic mesoporous silica nanoparticles (60-80 nm, IC50 = 121.98 μg/mL)23 , and
synthetic silicate nanoplatelets (25-30 nm, IC50 = 4 mg/mL)24 .

127

Figure 5.2. 10T1/2 cells morphology and attachment. Confocal fluorescent images of (A) Cells
cultured with hybrid microparticles for 4 and 7 days (green = intrinsic fluorescence of
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microparticles, blue = nuclei, red = F-actin) (B) Spreading of cells cultured on glass slide and
hybrid (blue = nuclei, red = F-actin) (C) Focal adhesions of cells cultured on glass slide and hybrid
(blue = nuclei, red = vinculin) (D) Measured cell area and (E) Number of focal adhesions per cell
for cultures on glass slide and hybrid. Different letters indicate the significance at p < 0.05, while
similar letters indicate no significance (p > 0.05). Scale bar = 20 μm.

Despite the fact that the cell type is an influential factor in assessing cytotoxicity, several studies
have shown that nano and submicron silica particles induce higher cytotoxicity comparable to
microparticles.25-27 Figure 5.3B shows the absorbance at 570 nm after 4 and 7 days, normalized to
the corresponding culture at day 1. The increased absorbance shows the increased metabolic
activity, indicating an increased number of cells. Using resazurin assay, it has been also showed
previously that the viability of cells embedded in 3D constructs of microparticles and fibrin gels
were stable in 4- and 7-days culture for two concentrations of 20 and 80 mg/mL microparticles. 11
Taken together with the current results shown in Figure 5.3, it can be concluded that hybrid
microparticles are well-tolerated by 10T1/2 cells. MTT assay measures the mitochondrial activity
of the cells as a measure of cell viability. In order to directly measure cell proliferation, CyQuant
Cell Proliferation Kit was used to quantify the DNA content of cultures. All cultured cells with
different concentrations of microparticles showed a statistically significant increase in cell number
after 7 days, compared to day 1 and day 4 (Figure 5.3C; p < 0.05), indicating that the hybrid
microparticles support the proliferation of cells. It has been reported that elevated concentrations
of Ca2+ increased the proliferation of both 10T1/2 cells and bone marrow derived MSCs. 28 This
may be the reason for the enhanced proliferation of 10T1/2 cells in the presence of microparticles
as well.
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Figure 5.3. 10T1/2 Cells metabolic activity and proliferation as determined by MTT and CyQuant
cell proliferation kit. (A) Metabolic activity of cells cultured with different concentrations of
hybrid microparticles for 1 day, normalized to tissue culture plate (B) Absorbance (at 570 nm) and
(C) Cell proliferation in presence of different concentrations of microparticles for 4 and 7 days,
normalized to corresponding day 1 culture. Different letters indicate the significance at p < 0.05,
while similar letters indicate no significance (p > 0.05).

5.4.3. Osteogenic gene expression of 10T1/2 cells
In order to evaluate the potential of hybrid microparticles to induce osteogenic differentiation,
PEA-BG microparticles in pristine and dexamethasone-loaded forms and with a concentration of
5 mg/mL were added to cultures of 10T1/2 cells in basal culture medium without any osteogenic
media supplements. Figure 5.4 shows the expression of six osteogenic genes in cultures with
pristine and dexamethasone-loaded microparticles. Runx2 also known as cbfa1 (core binding
factor alpha 1) is the earliest osteogenic differentiation marker known29 and is one of the upstream
transcription factors of non-collagenous proteins characteristic of osteoblasts such as osteopontin,
osteocalcin, and bone sialoprotein.30 Runx2 deficient mutant mice showed a complete lack of bone
formation, showing its essential role in osteogenesis. 31 Figure 5.4A shows that runx2 expression
is upregulated significantly after 8 hours in the cultures with microparticles, while in the same time
point, in cultures with osteogenic media no upregulation was observed. It has been shown that
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runx2 is upregulated only after 24 hours in the cultures of 10T1/2 cells under the synergistic effect
of BMP2 and dexamethasone.32 Therefore, the presence of hybrid microparticles not only led to
significant upregulation of runx2 but also led to a peak at an earlier time point.

Expression of alkaline phosphatase (Alpl) is one of the known predictors of osteogenic
differentiation. The elevated expression of Alpl in hard tissue formation appeared to serve two
purposes, decreasing the concentration of inorganic pyrophosphate, an inhibitor of mineralization,
and increasing the concentration of inorganic phosphate, a promoter of mineralization. 33 After 7
days of culture, Alpl expression was upregulated significantly in culture with microparticles.
Pristine microparticles resulted in 7.2 fold upregulation of Alpl, slightly higher than 5.4 fold
observed in cultures with osteogenic media. Dexamethasone-loaded microparticles resulted in 14.6
fold Alpl upregulation, which is significantly higher than both cultures with osteogenic media and
unloaded microparticles (Figure 5.4B).

Spp1 is the gene associated with osteopontin (OPN). Osteopontin is one of the non-collagenous
proteins of bone matrix, released from both osteoblast and osteoclast, which plays a key role in
bone remodeling.34 Similar to the observation made for Alpl, after 7 days of culture, pristine hybrid
microparticles upregulated the expression of Spp1 to a level comparable to osteogenic media
cultures and significantly higher than the normal media. Dexamethasone-loaded microparticles
resulted in a much higher upregulation (114.8 fold) compared to other groups (Figure 5.4C).
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Figure 5.4. 10T1/2 cells osteogenic gene expression. (A) Runx2 (B) Alpl (C) Spp1 (D) Sp7 (E)
Bglap and (F) IBSP mRNA expression of 10T1/2 cells cultured with osteogenic media and normal
media containing 5 mg/mL PEA-BG microparticles (n = 4). Results were normalized to GAPDH
expression. Different letters indicate the significance at p < 0.05, while similar letters indicate no
significance (p > 0.05).

Osterix is another key transcription factor in the osteogenesis process, essential for the
differentiation of pre-osteoblasts into mature osteoblasts. The absence of osterix expression in
runx2 null mice suggested that osterix is downstream of runx2. In addition, in osterix null mice no
endochondral or intramembranous bone formation occurred. 35 After 4 days, the expression of Sp7,
the gene associated with osterix, was significantly upregulated in cultures with microparticles.
Dexamethasone-loaded MPs resulted in significantly higher upregulation compared to pristine
MPs as well (Figure 5.4D).
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Bglap is one of the genes which encodes osteocalcin (OCN). OCN is another non-collagenous
protein in bone and its synthesis is largely restricted to osteoblasts. OCN having three carboxylated
glutamic acid residues has a binding affinity for Ca2+ and is essential for the alignment of apatite
crystals in the mineralization process.36 Here, OCN was upregulated significantly after 4 days
(Figure 5.4E). Interestingly, pristine microparticles resulted in significantly higher upregulation
compared to dexamethasone-loaded particles. OCN is considered a relatively late osteogenic
marker, related to osteoblasts maturation and indicating the onset of mineralization. However, in
cultures of bone marrow derived human mesenchymal stromal cells on biomineralized collagen
membranes,37 or osteoblast precursor MC3T3-E1 cells with bioactive glass conditioned media,38
OCN upregulation has been detected as early as 3 days. 10T1/2 cells treated with BMP7 have also
shown the expression of OCN after 4 days.39 The earlier expression of OCN may suggest that
hybrid microparticles not only promoted cell differentiation but also causing the cells to enter the
maturation and mineralization stage at an earlier time point.

Bone sialoprotein (BSP), another major non-collagenous protein of bone extracellular matrix, is
expressed primarily in mature osteoblasts at late stages of differentiation,40 and is considered as a
potential nucleation site for hydroxyapatite. 41 After 4 days, the expression of IBSP, the gene
associated with BSP, was significantly upregulated in cultures with microparticles, while in the
same time point, in cultures with osteogenic media no upregulation was observed (Figure 5.4F).

5.4.4. Western blot analysis
The expressions of two osteogenesis proteins were evaluated by western blot analysis after 7- and
14-days cultures (Figure 5.5). OPN was detected in all cultures, in both time points of 7 and 14
days; however, the expression was more pronounced in cultures with osteogenic media and
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dexamethasone-loaded MPs compared to cultures with pristine MPs. For all samples, the protein
expression was increased from 7 days to 14 days. In contrast, OCN was only detected in cultures
with microparticles (both pristine and dexamethasone-loaded MPs); however, the expression was
higher in cultures with dexamethasone-loaded MPs. Similar to OPN expression, the OCN protein
expression was increased after 14 days compared to 7 days culture.
Osteopontin and osteocalcin are key contributors to osteogenesis and play biological and
mechanical roles in bone formation. As components of the extracellular matrix, they not only
modulate cell-matrix interaction but also influence matrix-mineral interaction and therefore affect
bone mass, mineral size, bone structure and morphology, and presumably mechanical properties
of bone.42 In OCN knock down human mesenchymal stromal cells, the mineral maturation was
delayed and the mineral to matrix ratio was significantly lower compared to the control group. 43
Mesenchymal stem cells lacking both OCN and OPN showed reduced proliferation, reduced
osteogenesis and angiogenesis potential, and delayed mineralized matrix maturation as well. 44 In
mutant mouse, lacking both OPN and OCN, significant changes in cortical area and length was
observed.42 It has been reported that exogenous supplementation of OCN and OPN enhanced
osteogenesis in both 2D and 3D culture systems as well as in vivo.44-46 Therefore, the expression
of OCN and OPN is an important indicator of osteogenic differentiation of 10T1/2 cells.
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Figure 5.5. Western blot analysis of osteogenic proteins, osteopontin and osteocalcin, following
7- and 14-days culture. Predicted band size for osteopontin is 66 and 32 kD (full length and MMPcleaved osteopontin) and for osteocalcin is 11 kD.

5.4.5. Evaluation of mineralization
Mineralization of the extracellular matrix is the ultimate phenotype of osteogenic tissue. Using
alizarin red staining, the mineral formation can be detected and quantified in cultures. Osteogenic
media provides an external source of phosphate (inorganic phosphate or β-glycerophosphate) to
facilitate mineralization. It is believed that the dissolution of inorganic components of the hybrid
microparticles provides phosphate alongside silicon and calcium ions, which potentially can
substitute the external phosphate source present in the osteogenic media. Alizarin red staining of
cultures after 10 days showed mineral deposition in both cases of pristine and dexamethasoneloaded microparticles, while the osteogenic media did not show any mineral deposition. Figure
5.6A shows the optical images of cultures after 14 days. After 14 days of culture, a significantly
higher level of minerals was deposited in cultures with microparticles compared to 10 days of
culture. Cultures with osteogenic media also showed mineral deposition after 14 days, to a level
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slightly lower than cultures with MPs (Figure 5.6B). Expression of runx2 after only 8 hours
followed by early expression of OCN after 4 days in the case of cultures with hybrid microparticles
might have resulted in early mineralization observed in cultures with microparticles after 10 days.

Figure 5.6. Alizarin red staining (A) Optical images showing the deposition of the mineralized
matrix (stained red) on day 14 (B) Quantification of mineralization by extraction of alizarin red
from cultures after 10- and 14-days culture. Different letters indicate the significance at p < 0.05,
while similar letters indicate no significance (p > 0.05). Scale bar = 100 μm.

5.4.6. Evaluation of mechanical properties
Figure 5.7A shows the stress-strain curves for hybrid materials and PEA. The hybrid materials
showed an initial elastic deformation up to the yield stress, followed by plastic deformation. The
presence of the inorganic phase in the hybrid resulted in enhanced compressive modulus
(214.4±32.4 MPa and 319.6±49 MPa) compared to the PEA alone (178.7±29.4 MPa) (Figure
5.7B). Comparing the two hybrid materials with different inorganic phase compositions revealed
that the hybrid with higher silica content had higher compressive modulus (Figure 5.7C). In
contrast to modulus, there was no significant difference in toughness between PEA and hybrids.
The organic content of the hybrid, the molecular weight and structure of the organic phase, 47 the
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composition of the inorganic phase, and the interaction between organic and inorganic phases48
are among factors affecting the mechanical properties of hybrid materials.

Figure 5.7. Mechanical properties of PEA and hybrid materials (A) Representative stress-strain
curves of hybrids and PEA (B, C) Compressive modulus and toughness of hybrids and PEA.
Toughness values were calculated by integrating stress-strain curves up to the strain of 0.3.
Different letters indicate the significance at p < 0.05, while similar letters indicate no significance
(p > 0.05).

Previously reported PCL-BG hybrid with similar composition had shown higher compressive
modulus compared to PEA-BG. This can be due to the higher measured mechanical strength of
PCL in comparison to PEA, in light of its higher molecular weight comparable to the PEA tested
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here.49 Hybrids of silica and poly(CL-co-GPTMS) with 60% organic content showed similar
compressive modulus and ultimate stress as the PEA-BG hybrid.50 It has been shown that the
compression modulus decreases while the strain at failure increases by increasing the organic
content of poly(CL-co-GPTMS)-silica and PCL-BG hybrids.49, 50 Both hybrids studied here have
50% PEA; therefore, the significant difference in compressive modulus of them stems from the
composition of inorganic phase. Having 10% CaCl2 , the compositions difference lies in silica and
phosphorous content. PEA-BG (85Si) having 85% silica showed a higher compressive modulus.
Both Si and P are considered to be network formers in the inorganic structures; however, 29 Si and
31 P

NMR studies of the sol-gel bioactive glasses have shown that phosphorous predominately

appears as orthophosphate ions, charge-balanced with cations such as Ca2+ and Na+.51, 52 In the
absence of enough network modifier cations or presence of other anions competing for charge
compensation such as boron,53 and in compositions with high P content, phosphorus appears as
pyrophosphate and Si-O-P,54 and might form phosphorus-rich regions of 1.5-2 nm in size.52 Given
the fact that the network modifiers cations are consumed for charge-balancing with orthophosphate
ions instead of the non-bridging oxygens, the silica network connectivity increases, and
subsequently the mechanical strength of the glass increases. Interestingly, here an opposite trend
was obtained. It should be noted that in the mentioned references, the bioactive glasses underwent
high-temperature thermal treatment, which is known to incorporate oxides in the glass network
and increase the network connectivity. Moreover, the maximum phosphorus content in those
studies was 6 mol%, while in the case of our PEA-BG (70Si), the BG contained 20% phosphorus.
Since the thermal treatment is not feasible in the case of hybrids, it is believed that the network
connectivity does not change, but the higher silica content with a covalently bonded network
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structure comparable to the electrostatic interactions of Ca and phosphate-rich regions resulted in
higher compressive modulus.
The compressive modulus and toughness measured here are indicative of the effect of presence of
inorganic phase and its composition on the mechanical properties of hybrids; however, the actual
mechanical properties depend on the shape of the tissue engineering construct, as well as its
degradability in vivo. Moreover, despite the fact that here the microparticles are compressed to
form cylindrical specimens, the fusion of microparticles might have not been complete in regions
of specimens and this might cause more deformation under stress.

5.5.

Conclusion

This study demonstrates that PEA-BG hybrid microparticles create a microenvironment that
promotes osteogenic differentiation. Release of silicon, calcium, and phosphate ions from MPs, as
well as loaded dexamethasone induced osteogenic differentiation in the absence of any additional
factor. The hybrid material supported cell spreading and formation of focal adhesions similar to
glass slides after 24 hours. Cell proliferation was maintained in the presence of different
concentrations of microparticles. The gene expression profile, the protein expression, and
mineralization conclusively showed that a single dose of pristine or dexamethasone-loaded hybrid
microparticles can induce osteogenic differentiation in the absence of any media supplement.
Given the fact that hybrid microparticles can be loaded with two different active agents, the dualloaded microparticles may have the potential to not only induce osteogenic differentiation but also
address other issues associated with bone defects such as infection through the release of suitable
active agents. Moreover, these hybrid MPs can potentially be incorporated in cell embedded
hydrogels to direct cell lineage commitment in a 3D microenvironment.
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Chapter 6
6. General Discussion and Conclusions
Overview: This chapter summarizes the research, discusses the strengths and limitations of the
current work, and recommends future directions.

6.1.

Summary

The focus of the research was to develop organic-inorganic hybrid biomaterials from poly(ester
amide) and silica/tertiary bioactive glass (PEA-SiO 2 / PEA-BG) for drug delivery and bone tissue
engineering applications. Bioactive glasses have been extensively investigated for bone tissue
engineering application because of their bioactivity, which means a hydroxyapatite layer similar
to the inorganic phase of bone forms on their surface. Upon their interaction with body fluids, they
bond to the surrounding bone tissue. In addition, they are osteoconductive through the release of
stimulatory ions (Si, Ca, etc.), which act as cues for cells. Due to the brittle nature of the bioactive
glasses, and the problems associated with their processing, the incorporation of polymers not only
can provide synergistic properties such as processability and toughness but also may provide
additional functionalities. While composite and nanocomposites of polymers and inorganic glasses
meet some of these expectations, organic-inorganic hybrids, in which the two phases are mixed on
the molecular level, act as a single-phase homogenous material with uniform and reproducible
properties.1
Notwithstanding the clear benefits of organic-inorganic hybrids, there are several challenges for
their synthesis. First, the inorganic glasses are synthesized through sol-gel reaction, which is an
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aqueous process and obtaining a homogenous single-phase hybrid to have uniform properties with
water-insoluble organic polymers can be challenging. Second, inorganic glasses normally undergo
high-temperature treatment after the sol-gel process to establish desired structural changes or to
incorporate elements such as calcium from their salt precursors in the inorganic network. However,
the high-temperature treatment is not feasible for hybrids due to the decomposition of the organic
polymer. Due to the essential role of calcium for bone tissue engineering applications, many
studies have focused on incorporating calcium in hybrids by using calcium alkoxides. Although
calcium alkoxides provide the possibility of incorporation of calcium in bioactive glasses at low
temperatures, their high reactivity leads to uncontrollably fast gelation, spare no time for
processing of the hybrids, and may even cause inhomogeneity in the final hybrid material.
In Chapter 3, hydrophobic PEA was incorporated into the glass network using water-miscible
organic solvents. By carefully adjusting precursor ratios, calcium was also incorporated in the
glass network using calcium ethoxide as a precursor while having a 3 h window of operation before
gelation. The final PEA-BG (BG: SiO 2 -CaO-P2 O5 ) hybrid material was homogenous as evidenced
by EDX elemental mapping (Figure 3.4). To modulate the microenvironment of the cells, apart
from the release of stimulatory ions from the inorganic phase of hybrid, mesoporous silica
nanoparticles (MSNs) were incorporated within the hybrid scaffolds as a biomolecule delivery
carrier (Figure 3.1). A slow-release rate was observed with 45% cumulative release after 20 days
for FITC as a model compound.2
In Chapter 4, intrinsically fluorescent PEA-BG microparticles were prepared and studied. The
PEA used in the current study was derived from L-Phenylalanine, which possesses intrinsic
fluorescence. This intrinsic fluorescence property was explored to provide drug delivery
functionality without the use of an additional carrier. Fluorescent bioactive dual-drug loaded PEA145

SiO2 and PEA-BG (BG: SiO 2 -CaCl2 -P2 O5 ) hybrid microparticles were thus prepared (Figure). The
hybrid microparticles were loaded with one or two compounds during the synthesis process
without a need for any additional post-synthesis processing. Both hydrophilic and hydrophobic
compounds can be loaded in the microparticles. Apart from bioactivity and osteoconductivity
(stemming from the inorganic phase) and intrinsic fluorescence (stemming from PEA), the
microparticles can provide both burst and sustained release profiles d epending on the loaded
compound(s) of interest (Figure). The synthesis process was simple and versatile and preserved
the biodegradable polymer component from degradation during the synthesis process. Different
organic polymers, different compositions of bioactive glass, and different organic/inorganic ratios
have yielded hybrid microparticles without modification of the process. Incorporation of the hybrid
microparticles in 3D fibrin hydrogels with embedded 10T1/2 cells showed the cytocompatibility
of hybrid microparticles.3
In Chapter 5, the potential of hybrid microparticles loaded with dexamethasone was investigated
to induce osteogenic differentiation of mesenchymal-like progenitor cells. It was shown that both
dexamethasone-loaded hybrid microparticles and pristine microparticles can induce the
differentiation of cells towards osteogenic lineage in the absence of differentiation media
supplements. The use of osteogenic media supplements in studies of biomaterials for bone
regeneration is a common practice, even though this experimental design does not simulate the in
vivo conditions. Therefore, the study took a step further and investigated the effect of the
biomaterial alone. The ability of microparticles to induce differentiation was demonstrated through
osteogenic genes and proteins expression experiments as well as mineralization evaluation.
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6.2.

Strengths and Limitations

This is the first work on incorporating PEA in an organic-inorganic hybrid system. While the use
of calcium alkoxides is challenging especially in a hybrid system due to the uncontrollably fast
gelation and subsequently inhomogeneity, homogenous PEA-BG hybrid using calcium ethoxide
were synthesized in a controlled manner. Although hybrid scaffolds were conveniently fabricated
using compression molding and salt leaching techniques, using this scaffold fabrication technique
resulted in the loss of some portion of the loaded compound in MSNs, which can be considerable
for hydrophilic compounds. Providing covalent linkage between the MSN pore wall and the loaded
compound can reduce the loss of compound during salt leaching steps as carried out in this study
through reacting isothiocyanates with amine groups to form thiourea linkages between FITC
molecules and MSNs.
To the best of our knowledge, this is the first work on the synthesis of homogenous organicinorganic hybrid microparticles using a hydrophobic polymer under acidic sol-gel conditions. The
synthesis process presented for the preparation of hybrid microparticles avoided typical multi-step
complex similar processes. Moreover, due to the two-stage nature of the synthesis process, a wide
variety of compounds with different solubilities can be loaded into the microparticles during the
synthesis. These hybrid microparticles are a good example of utilizing both ind ividual and
synergistic properties of materials such as bioactivity, osteoconductivity, intrinsic fluorescence,
and drug delivery potential. However, the size of final microparticles cannot be varied
considerably, and generally, the microparticles are polydisperse in size.
The hybrid microparticles induced osteogenic differentiation of 10T1/2 cells without the support
of any media supplement. Dexamethasone loaded into hybrid microparticles showed a 69% burst
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release in the first 24 hours. This burst release is mainly through the diffusion of loaded compound;
therefore, providing covalent interaction between the loaded compound and polymer can
potentially provide more control over the release profile and should be investigated further.
Moreover, depending on the loaded compound, the stability of the compound under acidic
conditions and the presence of organic solvents in the synthesis process should also be considered.
The experimental design of this part of the work involved the use of 2D culture systems.
Investigating the effect of hybrid microparticles on cells’ differentiation in 3D culture systems,
which is closer to the final intended application of the hybrid materials should be considered as
well.

6.3.

Future Directions

The current work introduced PEA-BG hybrid materials for bone regeneration and drug delivery in
the form of porous scaffold and spherical microparticles. Future work can broaden the scope of
these hybrids both from a materials engineering and biological perspective.
1.

Incorporating other inorganic components: The inorganic component of the current

hybrid contained SiO 2 , P2 O5, and CaO or CaCl2 . As shown specifically in the case of hybrid
microparticles, the molar composition of the inorganic phase of the hybrid can be changed easily.
Many studies have shown the notable influence of various ions on the osteogenesis process.
Copper,4 magnesium,5 manganese,6 strontium,7 zinc,8 , and boron9 were previously introduced into
the sol-gel process and incorporated in the bioactive glasses to enhance the specific cellular effect.
Therefore, exploring the incorporation of other elements in the PEA-inorganic hybrid materials
can enhance the potential biological effects of these hybrids. Changing the inorganic phase
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composition may also change the drug release rate from hybrid microparticles as different ion
release kinetics affects the degradation of the hybrids.

2.

Investigating poly(ester amide)s based on other amino acids: The PEA used in this

work was based on L-Phenylalanine, sebacoyl chloride, and butanediol. It is believed that the
intrinsic fluorescence of PEA stems from the L-Phenylalanine. However, using PEAs based on
other amino acids10, 11 can not only be used as a tool for modulation of degradation rate but also
can provide functional moieties for conjugation of biomolecules. Linking the active agent/drug
molecule to the polymer before the preparation of hybrid microparticles can be used as a tool to
obtain more sustained and on-demand release profiles. In the case of porous scaffolds, the
conjugation of the drug to the polymer can provide the dual-drug loading ability as well (one drug
loaded in MSNs and one drug conjugated to PEA).

3.

Investigating the biological performance of hybrid microparticle in 3D culture

systems or using microparticles loaded with different biomolecules:
Future work may also focus on the utilization of the two hybrid platforms (porous scaffolds and
microparticles) for more in-depth biological evaluation towards the final goal of bone regeneration.
As both morphologies have the potential to be loaded with active agents, the effect of the loaded
compound(s) alongside the release of stimulatory ions from the inorganic phase can be evaluated
on in vitro cell culture systems. The biological performance of hybrid microparticles in their
pristine form and loaded with dexamethasone was evaluated in the 2D culture system. The hybrid
microparticles have been incorporated in the 3D fibrin hydrogels with embedded 10T1/2 cells as
shown in Chapter 4. This hydrogel platform can also be used for the biological evaluation of hybrid
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microparticles in a 3D culture system. Moreover, the microparticles can be loaded with two
different compounds to investigate the synergistic effect of two loaded compounds on cells.

6.4.
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